{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:21:07Z","timestamp":1789096867771,"version":"build-2803163510"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005669","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado da Para\u00edba","doi-asserted-by":"publisher","award":["#030\/2023"],"award-info":[{"award-number":["#030\/2023"]}],"id":[{"id":"10.13039\/501100005669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB) is a leading infectious disease killer and one of the major causes of deaths worldwide. Although TB is a curable and preventable disease, in 2023, approximately 10.8 million people fell ill with TB and there were an estimated 1.25 million of deaths worldwide. Despite some research progress for new drug candidates, drug repurposing, and new regimens, there is still an urgent need for the new medicins to treat TB, especially due to the growing cases of multidrug and extensively drug-resistant (MDR\/XDR) strains. Drug resistance is a challenging obstacle to TB care and prevention globally, making TB harder and longer to treat, often with poorer outcomes for patients. The Actinomycetota encompass Gram-positive bacteria that produce a milieu of bioactive metabolites, including antibiotics, antiproliferative drugs, immunosuppressive agents, and other important medical molecules. Actinomycetota have a special place in the therapeutic arsenal to fight TB, as rifamycins, aminoglycosides, and cycloserine are derived from\n                    <jats:italic>Streptomyces<\/jats:italic>\n                    species, one of the most important genera in this phylum. Furthermore, hundreds of antimycobacterial metabolites have been isolated from Actinomycetota and can serve as effective drugs or useful agents for the discovery of new lead compounds to combat TB. The present review covers more than 171 isolated substances as potential antimycobacterial agents discovered between the years 1972 to 2024. Among the most potent compounds, with MIC in the submicromolar range, steffimycins, ilamycins\/rufomycins, nosiheptide, actinomycins, lassomycin and boromycin are the most promising compounds. These compounds represent highly promising candidates for development of new antitubercular drugs. Additionally, some of these substances also demonstrated activity against resistant\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (Mtb) strains, which is particularly relevant given the difficulty of treating MDR and XDR strains. Thus, actinobacteria have played and continue to play an important role in fight TB, remaining a promising source of antibiotic metabolites. Their unique metabolic diversity enables the production of metabolites with innovative mechanisms of action, making them a strategic reservoir for discovering therapies against untreatable forms of the disease.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s13659-025-00533-8","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T03:21:19Z","timestamp":1754882479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9547-7854","authenticated-orcid":false,"given":"Luana Layse C\u00e2mara","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8300-4623","authenticated-orcid":false,"given":"Sayoane Pessoa","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8940-1988","authenticated-orcid":false,"given":"Genil Dantas","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8145-0435","authenticated-orcid":false,"given":"Marcelly","family":"da Silveira Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6000-8747","authenticated-orcid":false,"given":"Thalisson Amorim","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-2249","authenticated-orcid":false,"given":"Valn\u00eas S.","family":"Rodrigues-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-8692","authenticated-orcid":false,"given":"Samuel Paulo","family":"Cibulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"3","key":"533_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.drudis.2016.11.015","volume":"22","author":"M Dong","year":"2017","unstructured":"Dong M, Pfeiffer B, Altmann KH. Recent developments in natural product-based drug discovery for tuberculosis. Drug Discov Today. 2017;22(3):585\u201391. https:\/\/doi.org\/10.1016\/j.drudis.2016.11.015.","journal-title":"Drug Discov Today"},{"issue":"10","key":"533_CR2","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3389\/fmicb.2019.01404","volume":"20","author":"JV Pham","year":"2019","unstructured":"Pham JV, Yilma MA, Feliz A, Majid MT, Maffetone N, Walker JR, et al. A review of the microbial production of bioactive natural products and biologics. Front Microbiol. 2019;20(10):1404. https:\/\/doi.org\/10.3389\/fmicb.2019.01404.","journal-title":"Front Microbiol"},{"issue":"1","key":"533_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/oxfordjournals.bmb.a071032","volume":"2","author":"A Fleming","year":"1944","unstructured":"Fleming A. The discovery of penicillin. Br Med Bull. 1944;2(1):4\u20135.","journal-title":"Br Med Bull"},{"key":"533_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127053","volume":"261","author":"D Maithani","year":"2022","unstructured":"Maithani D, Sharma A, Gangola S, Chaudhary P, Bhatt P. Insights into applications and strategies for discovery of microbial bioactive metabolites. Microbiol Res. 2022;261: 127053. https:\/\/doi.org\/10.1016\/j.micres.2022.127053.","journal-title":"Microbiol Res"},{"issue":"12","key":"533_CR5","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.drudis.2020.10.005","volume":"25","author":"A Hussain","year":"2020","unstructured":"Hussain A, Hassan QP, Shouche YS. New approaches for antituberculosis leads from Actinobacteria. Drug Discov Today. 2020;25(12):2335\u201342. https:\/\/doi.org\/10.1016\/j.drudis.2020.10.005.","journal-title":"Drug Discov Today"},{"issue":"70","key":"533_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-micro-102215-095748","volume":"8","author":"GR Lewin","year":"2016","unstructured":"Lewin GR, Carlos C, Chevrette MG, Horn HA, McDonald BR, Stankey RJ, et al. Evolution and ecology of Actinobacteria and their bioenergy applications. Annu Rev Microbiol. 2016;8(70):235\u201354. https:\/\/doi.org\/10.1146\/annurev-micro-102215-095748.","journal-title":"Annu Rev Microbiol"},{"issue":"12","key":"533_CR7","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1073\/pnas.95.12.6578","volume":"95","author":"WB Whitman","year":"1998","unstructured":"Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A. 1998;95(12):6578\u201383. https:\/\/doi.org\/10.1073\/pnas.95.12.6578.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"533_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2021.126708","volume":"246","author":"PA Jose","year":"2021","unstructured":"Jose PA, Maharshi A, Jha B. Actinobacteria in natural products research: progress and prospects. Microbiol Res. 2021;246: 126708. https:\/\/doi.org\/10.1016\/j.micres.2021.126708.","journal-title":"Microbiol Res"},{"issue":"1","key":"533_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MMBR.00019-15","volume":"80","author":"EA Barka","year":"2015","unstructured":"Barka EA, Vatsa P, Sanchez L, Gaveau-Vaillant N, Jacquard C, Meier-Kolthoff JP, et al. Taxonomy, physiology, and natural products of Actinobacteria. Microbiol Mol Biol Rev. 2015;80(1):1\u201343. https:\/\/doi.org\/10.1128\/MMBR.00019-15.","journal-title":"Microbiol Mol Biol Rev"},{"key":"533_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2019.126374","volume":"231","author":"R Salwan","year":"2020","unstructured":"Salwan R, Sharma V. Molecular and biotechnological aspects of secondary metabolites in actinobacteria. Microbiol Res. 2020;231: 126374. https:\/\/doi.org\/10.1016\/j.micres.2019.126374.","journal-title":"Microbiol Res"},{"issue":"10","key":"533_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41579-020-0379-y","volume":"18","author":"DA Van Bergeijk","year":"2020","unstructured":"Van Bergeijk DA, Terlouw BR, Medema MH, van Wezel GP. Ecology and genomics of Actinobacteria: new concepts for natural product discovery. Nat Rev Microbiol. 2020;18(10):546\u201358. https:\/\/doi.org\/10.1038\/s41579-020-0379-y.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"533_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/antibiotics10060682","volume":"10","author":"ML Hui","year":"2021","unstructured":"Hui ML, Tan LT, Letchumanan V, He YW, Fang CM, Chan KG, et al. The extremophilic actinobacteria: from microbes to medicine. Antibiotics. 2021;10(6):682. https:\/\/doi.org\/10.3390\/antibiotics10060682.","journal-title":"Antibiotics"},{"issue":"8","key":"533_CR13","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1099\/jmm.0.001232","volume":"69","author":"GA Quinn","year":"2020","unstructured":"Quinn GA, Banat AM, Abdelhameed AM, Banat IM. Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery. J Med Microbiol. 2020;69(8):1040\u20138. https:\/\/doi.org\/10.1099\/jmm.0.001232.","journal-title":"J Med Microbiol"},{"issue":"3","key":"533_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/microbiolres13030031","volume":"13","author":"L Donald","year":"2022","unstructured":"Donald L, Pipite A, Subramani R, Owen J, Keyzers RA, Taufa T. Streptomyces: still the biggest producer of new natural secondary metabolites, a current perspective. Microbiol Res. 2022;13(3):418\u201365. https:\/\/doi.org\/10.3390\/microbiolres13030031.","journal-title":"Microbiol Res"},{"issue":"13","key":"533_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.968053","volume":"29","author":"K Alam","year":"2022","unstructured":"Alam K, Mazumder A, Sikdar S, Zhao YM, Hao J, Song C, et al. Streptomyces: the biofactory of secondary metabolites. Front Microbiol. 2022;29(13): 968053. https:\/\/doi.org\/10.3389\/fmicb.2022.968053.","journal-title":"Front Microbiol"},{"issue":"2019","key":"533_CR16","doi-asserted-by":"publisher","first-page":"5283948","DOI":"10.1155\/2019\/5283948","volume":"1","author":"P Sivalingam","year":"2019","unstructured":"Sivalingam P, Hong K, Pote J, Prabakar K. Extreme environment Streptomyces: potential sources for new antibacterial and anticancer drug leads? Int J Microbiol. 2019;1(2019):5283948. https:\/\/doi.org\/10.1155\/2019\/5283948.","journal-title":"Int J Microbiol"},{"issue":"14","key":"533_CR17","doi-asserted-by":"publisher","first-page":"1285543","DOI":"10.3389\/fmicb.2023.1285543","volume":"14","author":"S Khan","year":"2023","unstructured":"Khan S, Srivastava S, Karnwal A, Malik T. Streptomyces as a promising biological control agents for plant pathogens. Front Microbiol. 2023;14(14):1285543. https:\/\/doi.org\/10.3389\/fmicb.2023.1285543.","journal-title":"Front Microbiol"},{"issue":"3","key":"533_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/MMBR.00005-07","volume":"71","author":"M Ventura","year":"2007","unstructured":"Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, Chater KF, et al. Genomics of actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev. 2007;71(3):495\u2013548. https:\/\/doi.org\/10.1128\/MMBR.00005-07.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"533_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02770-8","volume":"23","author":"M Saleem","year":"2023","unstructured":"Saleem M, Hassan A, Li F, Lu Q, Ponomareva LV, Parkin S, et al. Bioprospecting of desert actinobacteria with special emphases on griseoviridin, mitomycin C and a new bacterial metabolite producing Streptomyces sp. PU-KB10-4. BMC Microbiol. 2023;23(1): 69. https:\/\/doi.org\/10.1186\/s12866-023-02770-8.","journal-title":"BMC Microbiol"},{"key":"533_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2022.102762","volume":"77","author":"F Del Carratore","year":"2022","unstructured":"Del Carratore F, Hanko EK, Breitling R, Takano E. Biotechnological application of Streptomyces for the production of clinical drugs and other bioactive molecules. Curr Opin Biotechnol. 2022;77: 102762. https:\/\/doi.org\/10.1016\/j.copbio.2022.102762.","journal-title":"Curr Opin Biotechnol"},{"key":"533_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00437","volume":"11","author":"JF Guerrero-Garz\u00f3n","year":"2020","unstructured":"Guerrero-Garz\u00f3n JF, Zehl M, Schneider O, R\u00fcckert C, Busche T, Kalinowski J, et al. Streptomyces spp. from the marine sponge Antho dichotoma: analyses of secondary metabolite biosynthesis gene clusters and some of their products. Front Microbiol. 2020;11: 437. https:\/\/doi.org\/10.3389\/fmicb.2020.00437.","journal-title":"Front Microbiol"},{"issue":"1","key":"533_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95788-9","volume":"11","author":"AD Pati\u00f1o","year":"2021","unstructured":"Pati\u00f1o AD, Montoya-Giraldo M, Quintero M, L\u00f3pez-Parra LL, Bland\u00f3n LM, G\u00f3mez-Le\u00f3n J. Dereplication of antimicrobial biosurfactants from marine bacteria using molecular networking. Sci Rep. 2021;11(1): 16286. https:\/\/doi.org\/10.1038\/s41598-021-95788-9.","journal-title":"Sci Rep"},{"issue":"3","key":"533_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/molecules26030588","volume":"26","author":"KK Sivakala","year":"2021","unstructured":"Sivakala KK, Guti\u00e9rrez-Garc\u00eda K, Jose PA, Thinesh T, Anandham R, Barona-G\u00f3mez F, et al. Desert environments facilitate unique evolution of biosynthetic potential in Streptomyces. Molecules. 2021;26(3):588. https:\/\/doi.org\/10.3390\/molecules26030588.","journal-title":"Molecules"},{"key":"533_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107699","volume":"151","author":"X Peng","year":"2024","unstructured":"Peng X, Zeng Z, Hassan S, Xue Y. The potential of marine natural products: recent advances in the discovery of anti-tuberculosis agents. Bioorg Chem. 2024;151: 107699. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107699.","journal-title":"Bioorg Chem"},{"key":"533_CR25","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: WHO; 2024."},{"key":"533_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-023-03491-x","volume":"80","author":"J Palanivel","year":"2023","unstructured":"Palanivel J, Sounderrajan V, Thangam T, Rao SS, Harshavardhan S, Parthasarathy K. Latent tuberculosis: challenges in diagnosis and treatment, perspectives, and the crucial role of biomarkers. Curr Microbiol. 2023;80: 392. https:\/\/doi.org\/10.1007\/s00284-023-03491-x.","journal-title":"Curr Microbiol"},{"issue":"6","key":"533_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065202","volume":"24","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed SSR, Gunosewoyo H. Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. 2023;24(6): 5202. https:\/\/doi.org\/10.3390\/ijms24065202.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"533_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05994-z","volume":"21","author":"SJ Li","year":"2021","unstructured":"Li SJ, Li YF, Song WM, Zhang QY, Liu SQ, Xu TT, et al. Population aging and trends of pulmonary tuberculosis incidence in the elderly. BMC Infect Dis. 2021;21(1): 302. https:\/\/doi.org\/10.1186\/s12879-021-05994-z.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"533_CR29","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1128\/CMR.00036-20","volume":"33","author":"L Luies","year":"2020","unstructured":"Luies L, Preez I. The echo of pulmonary tuberculosis: mechanisms of clinical symptoms and other disease-induced systemic complications. Clin Microbiol Rev. 2020;33(4):e00036-e120. https:\/\/doi.org\/10.1128\/CMR.00036-20.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"533_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41579-018-0013-4","volume":"16","author":"S Ehrt","year":"2018","unstructured":"Ehrt S, Schnappinger D, Rhee KY. Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis. Nat Rev Microbiol. 2018;16(8):496\u2013507. https:\/\/doi.org\/10.1038\/s41579-018-0013-4.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"533_CR31","first-page":"E9","volume":"58","author":"I Barberis","year":"2017","unstructured":"Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: from the first historical records to the isolation of Koch\u2019s bacillus. J Prev Med Hyg. 2017;58(1):E9\u201312.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"533_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000029220","volume":"65","author":"H Herzog","year":"1998","unstructured":"Herzog H. History of tuberculosis. Respiration. 1998;65(1):5\u201315. https:\/\/doi.org\/10.1159\/000029220.","journal-title":"Respiration"},{"issue":"1","key":"533_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/infdis\/jiae477","volume":"231","author":"PC Karakousis","year":"2025","unstructured":"Karakousis PC, Mooney G. Respiratory isolation for tuberculosis: a historical perspective. J Infect Dis. 2025;231(1):3\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiae477.","journal-title":"J Infect Dis"},{"issue":"2","key":"533_CR34","doi-asserted-by":"publisher","first-page":"E143","DOI":"10.15167\/2421-4248\/jpmh2020.61.2.1402","volume":"61","author":"E Armocida","year":"2020","unstructured":"Armocida E, Martini M. Tuberculosis: a timeless challenge for medicine. J Prev Med Hyg. 2020;61(2):E143\u20137. https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2020.61.2.1402.","journal-title":"J Prev Med Hyg"},{"issue":"3","key":"533_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2022.104112","volume":"51","author":"GB Migliori","year":"2022","unstructured":"Migliori GB, Caminero Luna J, Kurhasani X, van den Boom M, Visca D, D\u2019Ambrosio L, et al. History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis. Presse Med. 2022;51(3): 104112. https:\/\/doi.org\/10.1016\/j.lpm.2022.104112.","journal-title":"Presse Med"},{"issue":"3","key":"533_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/1469-0691.12555","volume":"20","author":"E Cambau","year":"2014","unstructured":"Cambau E, Drancourt M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882. Clin Microbiol Infect. 2014;20(3):196\u2013201. https:\/\/doi.org\/10.1111\/1469-0691.12555.","journal-title":"Clin Microbiol Infect"},{"issue":"13","key":"533_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25133011","volume":"25","author":"M Maiolini","year":"2020","unstructured":"Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, et al. The war against tuberculosis: a review of natural compounds and their derivatives. Molecules. 2020;25(13): 3011. https:\/\/doi.org\/10.3390\/molecules25133011.","journal-title":"Molecules"},{"issue":"2","key":"533_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100037","volume":"27","author":"AD Bendre","year":"2021","unstructured":"Bendre AD, Peters PJ, Kumar J. Tuberculosis: past, present and future of the treatment and drug discovery research. Curr Res Pharmacol Drug Discov. 2021;27(2): 100037. https:\/\/doi.org\/10.1016\/j.crphar.2021.100037.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"533_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00158","volume":"8","author":"Q Chai","year":"2018","unstructured":"Chai Q, Zhang Y, Liu CH. Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases. Front Cell Infect Microbiol. 2018;8: 158. https:\/\/doi.org\/10.3389\/fcimb.2018.00158.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"533_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/viru.22329","volume":"4","author":"MA Forrellad","year":"2013","unstructured":"Forrellad MA, Klepp LI, Gioffr\u00e9 A, SabioyGarc\u00eda J, Morbidoni HR, de la Paz SM, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4(1):3\u201366. https:\/\/doi.org\/10.4161\/viru.22329.","journal-title":"Virulence."},{"issue":"8","key":"533_CR41","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1080\/21645515.2021.1885280","volume":"17","author":"T Cho","year":"2021","unstructured":"Cho T, Khatchadourian C, Nguyen H, Dara Y, Jung S, Venketaraman V. A review of the BCG vaccine and other approaches toward tuberculosis eradication. Hum Vaccin Immunother. 2021;17(8):2454\u201370. https:\/\/doi.org\/10.1080\/21645515.2021.1885280.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"533_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/imr.12968","volume":"301","author":"A Ahmed","year":"2021","unstructured":"Ahmed A, Rakshit S, Adiga V, Dias M, Dwarkanath P, D\u2019Souza G, et al. A century of BCG: impact on tuberculosis control and beyond. Immunol Rev. 2021;301(1):98\u2013121. https:\/\/doi.org\/10.1111\/imr.12968.","journal-title":"Immunol Rev"},{"issue":"1","key":"533_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03944-8","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Gao L, Wu X, Fan Y, Liu M, Peng L, et al. BCG-induced trained immunity: history, mechanisms and potential applications. J Transl Med. 2023;21(1): 106. https:\/\/doi.org\/10.1186\/s12967-023-03944-8.","journal-title":"J Transl Med"},{"issue":"13","key":"533_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.959656","volume":"26","author":"S Singh","year":"2022","unstructured":"Singh S, Saavedra-Avila NA, Tiwari S, Porcelli SA. A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19. Front Immunol. 2022;26(13): 959656. https:\/\/doi.org\/10.3389\/fimmu.2022.959656.","journal-title":"Front Immunol"},{"issue":"4","key":"533_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijtb.2024.05.003","volume":"71","author":"BD Daniel","year":"2024","unstructured":"Daniel BD, Venkatesan M, Padmapriyadarsini C. Safety profile of BCG revaccination for COVID prevention among elderly individuals in India. Indian J Tuberc. 2024;71(4):380\u20132. https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.003.","journal-title":"Indian J Tuberc"},{"issue":"43","key":"533_CR46","doi-asserted-by":"publisher","first-page":"17317","DOI":"10.1073\/pnas.1215761109","volume":"109","author":"P Aaby","year":"2012","unstructured":"Aaby P, Benn CS. Saving lives by training innate immunity with bacille Calmette-Gu\u00e9rin vaccine. Proc Natl Acad Sci USA. 2012;109(43):17317\u20138. https:\/\/doi.org\/10.1073\/pnas.1215761109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"533_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.25061\/2527-2675\/ReBraM\/2019.v22i2.678","volume":"22","author":"AC Massabni","year":"2019","unstructured":"Massabni AC, Bonini EH. Tuberculose: hist\u00f3ria e evolu\u00e7\u00e3o dos tratamentos da doen\u00e7a. Rev Bras Multidiscip. 2019;22(2):6\u201334. https:\/\/doi.org\/10.25061\/2527-2675\/ReBraM\/2019.v22i2.678.","journal-title":"Rev Bras Multidiscip"},{"issue":"3062","key":"533_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1126\/science.118.3062.259","volume":"118","author":"SA Waksman","year":"1953","unstructured":"Waksman SA. Streptomycin: background, isolation, properties, and utilization. Science. 1953;118(3062):259\u201366. https:\/\/doi.org\/10.1126\/science.118.3062.259.","journal-title":"Science"},{"issue":"2","key":"533_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.23882\/rmd.22098","volume":"4","author":"C Fiolhais","year":"2022","unstructured":"Fiolhais C. Uma Breve Hist\u00f3ria da Tuberculose em Portugal. Rev Multidiscip. 2022;4(2):41\u201355. https:\/\/doi.org\/10.23882\/rmd.22098.","journal-title":"Rev Multidiscip"},{"issue":"9","key":"533_CR50","doi-asserted-by":"publisher","first-page":"e00860","DOI":"10.1128\/AAC.00860-20","volume":"64","author":"KA Cohen","year":"2020","unstructured":"Cohen KA, Stott KE, Munsamy V, Manson AL, Earl AM, Pym AS. Evidence for expanding the role of streptomycin in the management of drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2020;64(9):e00860-e920. https:\/\/doi.org\/10.1128\/AAC.00860-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"533_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7476\/9788575412886","volume-title":"Hist\u00f3ria social da tuberculose e do tuberculoso: 1900\u20131950","author":"C Bertolli Filho","year":"2001","unstructured":"Bertolli Filho C. Hist\u00f3ria social da tuberculose e do tuberculoso: 1900\u20131950. Rio de Janeiro: Editora Fiocruz; 2001. p. 248."},{"issue":"10","key":"533_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMra1205429","volume":"367","author":"S Keshavjee","year":"2012","unstructured":"Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med. 2012;367(10):931\u20136. https:\/\/doi.org\/10.1056\/NEJMra1205429.","journal-title":"N Engl J Med"},{"issue":"12","key":"533_CR53","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1513\/AnnalsATS.201509-632PS","volume":"12","author":"JF Murray","year":"2015","unstructured":"Murray JF, Schraufnagel DE, Hopewell PC. Treatment of tuberculosis. A historical perspective. Ann Am Thorac Soc. 2015;12(12):1749\u201359. https:\/\/doi.org\/10.1513\/AnnalsATS.201509-632PS.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"533_CR54","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/clinids\/5.supplement_3.s402","volume":"5","author":"P Sensi","year":"1983","unstructured":"Sensi P. History of the development of rifampin. Rev Infect Dis. 1983;5(3):402\u20136. https:\/\/doi.org\/10.1093\/clinids\/5.supplement_3.s402.","journal-title":"Rev Infect Dis"},{"key":"533_CR55","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001566","author":"KR Hardie","year":"2022","unstructured":"Hardie KR, Fenn SJ. JMM profile: rifampicin: a broad-spectrum antibiotic. J Med Microbiol. 2022. https:\/\/doi.org\/10.1099\/jmm.0.001566.","journal-title":"J Med Microbiol"},{"key":"533_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.103937","volume":"74","author":"M Grobbelaar","year":"2019","unstructured":"Grobbelaar M, Louw GE, Sampson SL, van Helden PD, Donald PR, Warren RM. Evolution of rifampicin treatment for tuberculosis. Infect Genet Evol. 2019;74: 103937. https:\/\/doi.org\/10.1016\/j.meegid.2019.103937.","journal-title":"Infect Genet Evol"},{"issue":"6","key":"533_CR57","first-page":"267","volume":"10","author":"H Ogawa","year":"1957","unstructured":"Ogawa H, It\u014d T. Chemistry of Kanamycin. I Degradation Products of Kanamycin. J Antibiot. 1957;10(6):267.","journal-title":"J Antibiot"},{"issue":"1","key":"533_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7883\/yoken1952.16.31","volume":"16","author":"Y Koseki","year":"1963","unstructured":"Koseki Y, Okamoto S. Studies on cross-resistance between capreomycin and certain other anti-mycobacterial agents. Jpn J Med Sci Biol. 1963;16(1):31\u20138. https:\/\/doi.org\/10.7883\/yoken1952.16.31.","journal-title":"Jpn J Med Sci Biol"},{"issue":"8","key":"533_CR59","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/ja01613a106","volume":"77","author":"PH Hidy","year":"1955","unstructured":"Hidy PH, Hodge EB, Young VV, Harned RL, Brewer GA, Phillips WF, et al. Structure and reactions of cycloserine. J Am Chem Soc. 1955;77(8):2345\u20136. https:\/\/doi.org\/10.1021\/ja01613a106.","journal-title":"J Am Chem Soc"},{"issue":"supply_3","key":"533_CR60","doi-asserted-by":"publisher","first-page":"S308","DOI":"10.1093\/cid\/ciy624","volume":"67","author":"D Deshpande","year":"2018","unstructured":"Deshpande D, Alffenaar JC, K\u00f6ser CU, Dheda K, Chapagain ML, Simbar N, et al. d-Cycloserine pharmacokinetics\/pharmacodynamics, susceptibility, and dosing implications in multidrug-resistant tuberculosis: a Faustian deal. Clin Infect Dis. 2018;67(supply_3):S308\u201316. https:\/\/doi.org\/10.1093\/cid\/ciy624.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"533_CR61","doi-asserted-by":"publisher","first-page":"e00141","DOI":"10.1128\/CMR.00141-20","volume":"34","author":"SN Goossens","year":"2020","unstructured":"Goossens SN, Sampson SL, Van Rie A. Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev. 2020;34(1):e00141-e220. https:\/\/doi.org\/10.1128\/CMR.00141-20.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"533_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00504-2","volume":"10","author":"K Dheda","year":"2024","unstructured":"Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, et al. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024;10(1): 22. https:\/\/doi.org\/10.1038\/s41572-024-00504-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"533_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","volume":"5","author":"K Dheda","year":"2017","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5(4):291\u2013360. https:\/\/doi.org\/10.1016\/S2213-2600(17)30079-6.","journal-title":"Lancet Respir Med"},{"key":"533_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2020.101574","volume":"74","author":"JL Khawbung","year":"2021","unstructured":"Khawbung JL, Nath D, Chakraborty S. Drug resistant tuberculosis: a review. Comp Immunol Microbiol Infect Dis. 2021;74: 101574. https:\/\/doi.org\/10.1016\/j.cimid.2020.101574.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"1","key":"533_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41937-9","volume":"14","author":"NA Menzies","year":"2023","unstructured":"Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP, et al. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nat Commun. 2023;14(1): 6182. https:\/\/doi.org\/10.1038\/s41467-023-41937-9.","journal-title":"Nat Commun"},{"issue":"224","key":"533_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113732","volume":"15","author":"G Cazzaniga","year":"2021","unstructured":"Cazzaniga G, Mori M, Chiarelli LR, Gelain A, Meneghetti F, Villa S. Natural products against key Mycobacterium tuberculosis enzymatic targets: emerging opportunities for drug discovery. Eur J Med Chem. 2021;15(224): 113732. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113732.","journal-title":"Eur J Med Chem"},{"key":"533_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.974101","volume":"12","author":"A Bhagwat","year":"2022","unstructured":"Bhagwat A, Deshpande A, Parish T. How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery. Front Cell Infect Microbiol. 2022;12: 974101. https:\/\/doi.org\/10.3389\/fcimb.2022.974101.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"533_CR68","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.joi.2016.10.006","volume":"10","author":"A Perianes-Rodriguez","year":"2016","unstructured":"Perianes-Rodriguez A, Waltman L, van Eck NJ. Constructing bibliometric networks: a comparison between full and fractional counting. J Informetr. 2016;10(4):1178\u201395. https:\/\/doi.org\/10.1016\/j.joi.2016.10.006.","journal-title":"J Informetr"},{"issue":"11","key":"533_CR69","doi-asserted-by":"publisher","first-page":"88042","DOI":"10.34117\/bjdv6n11-287","volume":"6","author":"LR Leite","year":"2020","unstructured":"Leite LR, Pereira NG, Santos GA, Versiani MS, Xavier MA, Cardoso L, et al. Estudo prospectivo de patentes relacionadas \u00e0 utiliza\u00e7\u00e3o de Streptomyces spp. em bioprocessos para produ\u00e7\u00e3o de antimicrobianos, antineopl\u00e1sicos e antiparasit\u00e1rios. Braz J Dev. 2020;6(11):88042\u201356.","journal-title":"Braz J Dev."},{"key":"533_CR70","unstructured":"Ribeiro R. Dom\u00ednio chin\u00eas em 37 das 44 tecnologias cr\u00edticas: Diplomacia cient\u00edfica e pol\u00edtica industrial. Rela\u00e7\u00f5es Exteriores. 2024. https:\/\/relacoesexteriores.com.br\/dominio-chines-em-37-das-44-tecnologias-criticas-diplomacia-cientifica-e-politica-industrial\/ (Accessed 2025 May 15)."},{"issue":"4","key":"533_CR71","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/microbiolres12040061","volume":"12","author":"P Laskaris","year":"2021","unstructured":"Laskaris P, Karagouni AD. Streptomyces, Greek habitats and novel pharmaceuticals: a promising challenge. Microbiol Res. 2021;12(4):840\u20136. https:\/\/doi.org\/10.3390\/microbiolres12040061.","journal-title":"Microbiol Res"},{"key":"533_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.148235","volume":"790","author":"S Li","year":"2021","unstructured":"Li S, Dong L, Lian W-H, Lin Z-L, Lu C-Y, Xu L, et al. Exploring untapped potential of Streptomyces spp. in Gurbantunggut Desert by use of highly selective culture strategy. Sci Total Environ. 2021;790: 148235. https:\/\/doi.org\/10.1016\/j.scitotenv.2021.148235.","journal-title":"Sci Total Environ"},{"issue":"7","key":"533_CR73","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/antibiotics11070965","volume":"11","author":"MC De la Hoz-Romo","year":"2022","unstructured":"De la Hoz-Romo MC, D\u00edaz L, Villamil L. Marine actinobacteria a new source of antibacterial metabolites to treat acne vulgaris disease\u2014a systematic literature review. Antibiotics. 2022;11(7):965. https:\/\/doi.org\/10.3390\/antibiotics11070965.","journal-title":"Antibiotics"},{"issue":"2","key":"533_CR74","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.sjbs.2021.11.055","volume":"29","author":"B Chakraborty","year":"2022","unstructured":"Chakraborty B, Kumar RS, Almansour AI, Gunasekaran P, Nayaka S. Bioprospection and secondary metabolites profiling of marine Streptomyces levis strain KS46. Saudi J Biol Sci. 2022;29(2):667\u201379. https:\/\/doi.org\/10.1016\/j.sjbs.2021.11.055.","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"533_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/md22010051","volume":"22","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun W, Hu Z, Wang W, Zhang H. Marine Streptomyces-derived novel alkaloids discovered in the past decade. Mar Drugs. 2024;22(1): 51. https:\/\/doi.org\/10.3390\/md22010051.","journal-title":"Mar Drugs"},{"issue":"2","key":"533_CR76","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10482-015-0502-7","volume":"108","author":"P Golinska","year":"2015","unstructured":"Golinska P, Wypij M, Agarkar G, Rathod D, Dahm H, Rai M. Endophytic actinobacteria of medicinal plants: diversity and bioactivity. Antonie Van Leeuwenhoek. 2015;108(2):267\u201389. https:\/\/doi.org\/10.1007\/s10482-015-0502-7.","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"4","key":"533_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12223-018-00673-0","volume":"64","author":"A Gohain","year":"2019","unstructured":"Gohain A, Sarma RK, Debnath R, Saikia J, Singh BP, Sarmah R, et al. Phylogenetic affiliation and antimicrobial effects of endophytic actinobacteria associated with medicinal plants: prevalence of polyketide synthase type II in antimicrobial strains. Folia Microbiol. 2019;64(4):481\u201396. https:\/\/doi.org\/10.1007\/s12223-018-00673-0.","journal-title":"Folia Microbiol"},{"key":"533_CR78","doi-asserted-by":"publisher","unstructured":"Harir M, Bendif H, Bellahcene M, Fortas Z, Pogni R. Streptomyces secondary metabolites. In: Basic Biology and Applications of Actinobacteria. IntechOpen; 2018. https:\/\/doi.org\/10.5772\/intechopen.79890.","DOI":"10.5772\/intechopen.79890"},{"key":"533_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00828","volume":"8","author":"S Agrawal","year":"2017","unstructured":"Agrawal S, Acharya D, Adholeya A, Barrow CJ, Deshmukh SK. Nonribosomal peptides from marine microbes and their antimicrobial and anticancer potential. Front Pharmacol. 2017;8: 828. https:\/\/doi.org\/10.3389\/fphar.2017.00828.","journal-title":"Front Pharmacol"},{"issue":"6","key":"533_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12060349","volume":"12","author":"MA Mart\u00ednez-N\u00fa\u00f1ez","year":"2020","unstructured":"Mart\u00ednez-N\u00fa\u00f1ez MA, Rodr\u00edguez-Escamilla Z. Mining the Yucatan coastal microbiome for the identification of non-ribosomal peptides synthetase (NRPS) genes. Toxins. 2020;12(6): 349. https:\/\/doi.org\/10.3390\/toxins12060349.","journal-title":"Toxins"},{"issue":"1","key":"533_CR81","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1128\/MMBR.70.1.121-146.2006","volume":"70","author":"J Gr\u00fcnewald","year":"2006","unstructured":"Gr\u00fcnewald J, Marahiel MA. Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides. Microbiol Mol Biol Rev. 2006;70(1):121\u201346. https:\/\/doi.org\/10.1128\/MMBR.70.1.121-146.2006.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"533_CR82","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1472-765X.2009.02689.x","volume":"49","author":"V Praveen","year":"2009","unstructured":"Praveen V, Tripathi CKM. Studies on the production of actinomycin-D by Streptomyces griseoruber \u2013 a novel source. Lett Appl Microbiol. 2009;49(4):450\u20135. https:\/\/doi.org\/10.1111\/j.1472-765X.2009.02689.x.","journal-title":"Lett Appl Microbiol"},{"issue":"11","key":"533_CR83","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14502","volume":"8","author":"KA Qureshi","year":"2023","unstructured":"Qureshi KA, Azam F, Fatmi MQ, Imtiaz M, Prajapati DK, Rai PK, et al. In vitro and in silico evaluations of actinomycin X2 and actinomycin D as potent anti-tuberculosis agents. PeerJ. 2023;8(11): e14502. https:\/\/doi.org\/10.7717\/peerj.14502.","journal-title":"PeerJ"},{"issue":"4","key":"533_CR84","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00253-012-4079-z","volume":"95","author":"C Chen","year":"2012","unstructured":"Chen C, Song F, Wang Q, Abdel-Mageed WM, Guo H, Fu C, et al. A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity. Appl Microbiol Biotechnol. 2012;95(4):919\u201327. https:\/\/doi.org\/10.1007\/s00253-012-4079-z.","journal-title":"Appl Microbiol Biotechnol"},{"key":"533_CR85","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.micpath.2017.06.017","volume":"110","author":"AM Shah","year":"2017","unstructured":"Shah AM, Shakeel UR, Hussain A, Mushtaq S, Rather MA, Shah A, et al. Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas. India Microb Pathog. 2017;110:93\u20139. https:\/\/doi.org\/10.1016\/j.micpath.2017.06.017.","journal-title":"India. Microb Pathog."},{"issue":"8","key":"533_CR86","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.22038\/ijbms.2021.56468.12601","volume":"24","author":"MD Rakhmawatie","year":"2021","unstructured":"Rakhmawatie MD, Wibawa T, Lisdiyanti P, Pratiwi WR, Damayanti E. Potential secondary metabolite from Indonesian Actinobacteria (InaCC A758) against Mycobacterium tuberculosis. Iran J Basic Med Sci. 2021;24(8):1058\u201368. https:\/\/doi.org\/10.22038\/ijbms.2021.56468.12601.","journal-title":"Iran J Basic Med Sci"},{"issue":"11","key":"533_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141658","volume":"10","author":"Y Ozeki","year":"2015","unstructured":"Ozeki Y, Igarashi M, Doe M, Tamaru A, Kinoshita N, Ogura Y, et al. A new screen for tuberculosis drug candidates utilizing a luciferase-expressing recombinant Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin. PLoS ONE. 2015;10(11): e0141658. https:\/\/doi.org\/10.1371\/journal.pone.0141658.","journal-title":"PLoS ONE"},{"issue":"40","key":"533_CR88","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1016\/j.tet.2011.07.053","volume":"67","author":"C Intaraudom","year":"2011","unstructured":"Intaraudom C, Rachtawee P, Suvannakad R, Pittayakhajonwut P. Antimalarial and antituberculosis substances from Streptomyces sp. BCC26924. Tetrahedron. 2011;67(40):7593\u20137. https:\/\/doi.org\/10.1016\/j.tet.2011.07.053.","journal-title":"Tetrahedron"},{"issue":"9\u201310","key":"533_CR89","doi-asserted-by":"publisher","DOI":"10.1093\/jimb\/kuab079","volume":"48","author":"C Chen","year":"2021","unstructured":"Chen C, Chen X, Ren B, Guo H, Abdel-Mageed WM, Liu X, et al. Characterization of Streptomyces sp. LS462 with high productivity of echinomycin, a potent antituberculosis and synergistic antifungal antibiotic. J Ind Microbiol Biotechnol. 2021;48(9\u201310): kuab079. https:\/\/doi.org\/10.1093\/jimb\/kuab079.","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"3","key":"533_CR90","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/acs.jnatprod.9b01095","volume":"83","author":"B Zhou","year":"2020","unstructured":"Zhou B, Shetye G, Yu Y, Santarsiero BD, Klein LL, Abad-Zapatero C, et al. Antimycobacterial rufomycin analogues from Streptomyces atratus strain MJM3502. J Nat Prod. 2020;83(3):657\u201367. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01095.","journal-title":"J Nat Prod"},{"issue":"5","key":"533_CR91","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/acs.jnatprod.0c00151","volume":"83","author":"C Sun","year":"2020","unstructured":"Sun C, Liu Z, Zhu X, Fan Z, Huang X, Wu Q, et al. Antitubercular ilamycins from marine-derived Streptomyces atratus SCSIO ZH16 \u0394 ilaR. J Nat Prod. 2020;83(5):1646\u201357. https:\/\/doi.org\/10.1021\/acs.jnatprod.0c00151.","journal-title":"J Nat Prod"},{"issue":"4","key":"533_CR92","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7164\/antibiotics.25.201","volume":"25","author":"R Izumi","year":"1972","unstructured":"Izumi R, Noda T, Ando T, Take T, Nagata A. Studies on tuberactinomycin. 3. Isolation and characterization of two minor components, tuberactinomycin B and tuberactinomycin O. J Antibiot (Tokyo). 1972;25(4):201\u20137.","journal-title":"J Antibiot (Tokyo)"},{"issue":"11","key":"533_CR93","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1021\/np400145u","volume":"76","author":"G Cai","year":"2013","unstructured":"Cai G, Napolitano JG, McAlpine JB, Wang Y, Jaki BU, Suh JW, et al. Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain. J Nat Prod. 2013;76(11):2009\u201318. https:\/\/doi.org\/10.1021\/np400145u.","journal-title":"J Nat Prod"},{"issue":"8","key":"533_CR94","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1021\/acs.orglett.9b00618","volume":"21","author":"Q Liu","year":"2019","unstructured":"Liu Q, Liu Z, Sun C, Shao M, Ma J, Wei X, et al. Discovery and biosynthesis of atrovimycin, an antitubercular and antifungal cyclodepsipeptide featuring vicinal-dihydroxylated cinnamic acyl chain. Org Lett. 2019;21(8):2634\u20138. https:\/\/doi.org\/10.1021\/acs.orglett.9b00618.","journal-title":"Org Lett"},{"issue":"1","key":"533_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03477-3","volume":"7","author":"TS Kim","year":"2017","unstructured":"Kim TS, Shin YH, Lee HM, Kim JK, Choe JH, Jang JC, et al. Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway. Sci Rep. 2017;7(1): 3431. https:\/\/doi.org\/10.1038\/s41598-017-03477-3.","journal-title":"Sci Rep"},{"issue":"9","key":"533_CR96","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1099\/00221287-148-9-2675","volume":"148","author":"UF Castillo","year":"2002","unstructured":"Castillo UF, Strobel GA, Ford EJ, Hess WM, Porter H, Jensen JB, et al. Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans. Microbiology. 2002;148(9):2675\u201385. https:\/\/doi.org\/10.1099\/00221287-148-9-2675.","journal-title":"Microbiology"},{"issue":"5","key":"533_CR97","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1021\/acs.orglett.9b00208","volume":"21","author":"C Sun","year":"2019","unstructured":"Sun C, Yang Z, Zhang C, Liu Z, He J, Liu Q, et al. Genome mining of Streptomyces atratus SCSIO ZH16: discovery of atratumycin and identification of its biosynthetic gene cluster. Org Lett. 2019;21(5):1453\u20137. https:\/\/doi.org\/10.1021\/acs.orglett.9b00208.","journal-title":"Org Lett"},{"issue":"8","key":"533_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24081495","volume":"24","author":"K Hosoda","year":"2019","unstructured":"Hosoda K, Koyama N, Kanamoto A, Tomoda H. Discovery of nosiheptide, griseoviridin, and etamycin as potent anti-mycobacterial agents against Mycobacterium avium complex. Molecules. 2019;24(8): 1495. https:\/\/doi.org\/10.3390\/molecules24081495.","journal-title":"Molecules"},{"issue":"6","key":"533_CR99","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1021\/ol5003913","volume":"16","author":"R Raju","year":"2014","unstructured":"Raju R, Khalil ZG, Piggott AM, Blumenthal A, Gardiner DL, Skinner-Adams TS, et al. Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244). Org Lett. 2014;16(6):1716\u20139. https:\/\/doi.org\/10.1021\/ol5003913.","journal-title":"Org Lett"},{"issue":"19","key":"533_CR100","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1021\/ol502472c","volume":"16","author":"ZG Khalil","year":"2014","unstructured":"Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ. Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces. Org Lett. 2014;16(19):5120\u20133. https:\/\/doi.org\/10.1021\/ol502472c.","journal-title":"Org Lett"},{"issue":"2","key":"533_CR101","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/AAC.04054-14","volume":"59","author":"W Gao","year":"2015","unstructured":"Gao W, Kim JY, Anderson JR, Akopian T, Hong S, Jin YY, et al. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrob Agents Chemother. 2015;59(2):880\u20139. https:\/\/doi.org\/10.1128\/AAC.04054-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"533_CR102","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"E Gavrish","year":"2014","unstructured":"Gavrish E, Sit CS, Cao S, Kandror O, Spoering A, Peoples A, et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem Biol. 2014;21(4):509\u201318. https:\/\/doi.org\/10.1016\/j.chembiol.2014.01.014.","journal-title":"Chem Biol"},{"issue":"12","key":"533_CR103","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1021\/acs.joc.7b00228","volume":"82","author":"D Dardic","year":"2017","unstructured":"Dardic D, Lauro G, Bifulco G, Laboudie P, Sakhaii P, Bauer A, et al. Svetamycins A-G, unusual piperazic acid-containing peptides from Streptomyces sp. J Org Chem. 2017;82(12):6032\u201343. https:\/\/doi.org\/10.1021\/acs.joc.7b00228.","journal-title":"J Org Chem"},{"issue":"10","key":"533_CR104","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/emmm.201201689","volume":"4","author":"RC Hartkoorn","year":"2012","unstructured":"Hartkoorn RC, Sala C, Neres J, Pojer F, Magnet S, Mukherjee R, et al. Towards a new tuberculosis drug: pyridomycin\u2013nature\u2019s isoniazid. EMBO Mol Med. 2012;4(10):1032\u201342. https:\/\/doi.org\/10.1002\/emmm.201201689.","journal-title":"EMBO Mol Med"},{"issue":"12","key":"533_CR105","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1007\/s00253-021-11226-w","volume":"105","author":"L Jiang","year":"2021","unstructured":"Jiang L, Huang P, Ren B, Song Z, Zhu G, He W, et al. Antibacterial polyene-polyol macrolides and cyclic peptides from the marine-derived Streptomyces sp. MS110128. Appl Microbiol Biotechnol. 2021;105(12):4975\u201386. https:\/\/doi.org\/10.1007\/s00253-021-11226-w.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"533_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/md20060400","volume":"20","author":"J Cui","year":"2022","unstructured":"Cui J, Kim E, Moon DH, Kim TH, Kang I, Lim Y, et al. Taeanamides A and B, nonribosomal lipo-decapeptides isolated from an intertidal-mudflat-derived Streptomyces sp. Mar Drugs. 2022;20(6): 400. https:\/\/doi.org\/10.3390\/md20060400.","journal-title":"Mar Drugs"},{"issue":"3","key":"533_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/md20030214","volume":"20","author":"F Song","year":"2022","unstructured":"Song F, Hu J, Zhang X, Xu W, Yang J, Li S, et al. Unique cyclized thiolopyrrolones from the marine-derived Streptomyces sp. BTBU20218885. Mar Drugs. 2022;20(3): 214. https:\/\/doi.org\/10.3390\/md20030214.","journal-title":"Mar Drugs"},{"issue":"2","key":"533_CR108","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3181\/00379727-45-11768","volume":"45","author":"SA Waksman","year":"1940","unstructured":"Waksman SA, Woodruff HB. Bacteriostatic and bactericidal substances produced by a soil actinomyces. Proc Soc Exp Biol Med. 1940;45(2):609\u201314. https:\/\/doi.org\/10.3181\/00379727-45-11768.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"7","key":"533_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076269","volume":"24","author":"W Zhou","year":"2023","unstructured":"Zhou W, Xie Z, Si R, Chen Z, Javeed A, Li J, et al. Actinomycin-X2-immobilized silk fibroin film with enhanced antimicrobial and wound healing activities. Int J Mol Sci. 2023;24(7): 6269. https:\/\/doi.org\/10.3390\/ijms24076269.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"533_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06736-0","volume":"12","author":"NV Machushynets","year":"2022","unstructured":"Machushynets NV, Elsayed SS, Du C, Siegler MA, de la Cruz M, Genilloud O, et al. Discovery of actinomycin L, a new member of the actinomycin family of antibiotics. Sci Rep. 2022;12(1): 2813. https:\/\/doi.org\/10.1038\/s41598-022-06736-0.","journal-title":"Sci Rep"},{"key":"533_CR111","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/AABC.S117707","volume":"10","author":"I Crnov\u010di\u0107","year":"2017","unstructured":"Crnov\u010di\u0107 I, R\u00fcckert C, Semsary S, Lang M, Kalinowski J, Keller U. Genetic interrelations in the actinomycin biosynthetic gene clusters of Streptomyces antibioticus IMRU 3720 and Streptomyces chrysomallus ATCC11523, producers of actinomycin X and actinomycin C. Adv Appl Bioinform Chem. 2017;10:29\u201346. https:\/\/doi.org\/10.2147\/AABC.S117707.","journal-title":"Adv Appl Bioinform Chem"},{"key":"533_CR112","first-page":"101","volume":"53","author":"VCA Ribeiro","year":"2022","unstructured":"Ribeiro VCA, Santos AMS, Ara\u00fajo LSF, Pessoa SS, Queiroz WJL. Screening of actinomycetes for anti-tuberculosis activity from Caatinga soil. Braz J Microbiol. 2022;53:101\u201310.","journal-title":"Braz J Microbiol"},{"issue":"9","key":"533_CR113","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/neuonc\/noaa172","volume":"22","author":"G Finocchiaro","year":"2020","unstructured":"Finocchiaro G. Actinomycin D: a new opening for an old drug. Neuro Oncol. 2020;22(9):1235\u20136. https:\/\/doi.org\/10.1093\/neuonc\/noaa172.","journal-title":"Neuro Oncol"},{"key":"533_CR114","first-page":"1120452","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Q, Wang Z, Dong W, Cao Y. Advances in biosynthesis and pharmacology of actinomycins. Front Microbiol. 2023;14:1120452.","journal-title":"Front Microbiol"},{"key":"533_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s13068-017-0952-4","volume":"10","author":"B Wilbanks","year":"2017","unstructured":"Wilbanks B, Trinh CT. Comprehensive characterization of toxicity of fermentative metabolites on microbial growth. Biotechnol Biofuels. 2017;10: 262. https:\/\/doi.org\/10.1186\/s13068-017-0952-4.","journal-title":"Biotechnol Biofuels"},{"issue":"6","key":"533_CR116","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/mmi.14918","volume":"117","author":"A Erlandson","year":"2022","unstructured":"Erlandson A, Gade P, Menikpurage IP, Kim CY, Mera PE. The UvrA-like protein Ecm16 requires ATPase activity to render resistance against echinomycin. Mol Microbiol. 2022;117(6):1434\u201346. https:\/\/doi.org\/10.1111\/mmi.14918.","journal-title":"Mol Microbiol"},{"issue":"1","key":"533_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34437-9","volume":"13","author":"P Gade","year":"2023","unstructured":"Gade P, Erlandson A, Ullah A, Chen X, Mathews II, Mera PE, et al. Structural and functional analyses of the echinomycin resistance conferring protein Ecm16 from Streptomyces lasalocidi. Sci Rep. 2023;13(1): 7980. https:\/\/doi.org\/10.1038\/s41598-023-34437-9.","journal-title":"Sci Rep"},{"issue":"4","key":"533_CR118","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF00170766","volume":"3","author":"BJ Foster","year":"1985","unstructured":"Foster BJ, Clagett-Carr K, Shoemaker DD, Suffness M, Plowman J, Trissel LA, et al. Echinomycin: the first bifunctional intercalating agent in clinical trials. Invest New Drugs. 1985;3(4):403\u201310. https:\/\/doi.org\/10.1007\/BF00170766.","journal-title":"Invest New Drugs"},{"issue":"13","key":"533_CR119","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1021\/ja711188x","volume":"130","author":"AW Schultz","year":"2008","unstructured":"Schultz AW, Oh DC, Carney JR, Williamson RT, Udwary DW, Jensen PR, et al. Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin. J Am Chem Soc. 2008;130(13):4507\u201316. https:\/\/doi.org\/10.1021\/ja711188x.","journal-title":"J Am Chem Soc"},{"key":"533_CR120","first-page":"1204455","volume":"15","author":"J Fei","year":"2024","unstructured":"Fei J, Zhang Y, Lu Y, Qiu M, Liu H, Li C, et al. Structural insights into cyclomarin analogues and their differential bioactivities. Front Microbiol. 2024;15:1204455.","journal-title":"Front Microbiol"},{"issue":"45","key":"533_CR121","doi-asserted-by":"publisher","first-page":"9698","DOI":"10.1021\/acs.orglett.4c03473","volume":"26","author":"F Fei","year":"2024","unstructured":"Fei F, Lun S, Saxena A, Raghavan M, DeRisi JL, Bishai WR, et al. Total syntheses of cyclomarin and metamarin natural products. Org Lett. 2024;26(45):9698\u2013703. https:\/\/doi.org\/10.1021\/acs.orglett.4c03473.","journal-title":"Org Lett"},{"issue":"15","key":"533_CR122","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1042\/BCJ20160014","volume":"473","author":"PG Gettins","year":"2016","unstructured":"Gettins PG, Olson ST. Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance. Biochem J. 2016;473(15):2273\u201393. https:\/\/doi.org\/10.1042\/BCJ20160014.","journal-title":"Biochem J"},{"issue":"2","key":"533_CR123","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/bcp.12403","volume":"79","author":"A Tseng","year":"2015","unstructured":"Tseng A, Seet J, Phillips EJ. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol. 2015;79(2):182\u201394. https:\/\/doi.org\/10.1111\/bcp.12403.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"533_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04658-9","volume":"6","author":"G Taylor","year":"2023","unstructured":"Taylor G, Cui H, Leodolter J, Giese C, Weber-Ban E. ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation. Commun Biol. 2023;6(1): 301. https:\/\/doi.org\/10.1038\/s42003-023-04658-9.","journal-title":"Commun Biol"},{"issue":"10","key":"533_CR125","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1021\/acs.jnatprod.1c00198","volume":"84","author":"B Zhou","year":"2021","unstructured":"Zhou B, Achanta PS, Shetye G, Chen SN, Lee H, Jin YY, et al. Rufomycins or ilamycins: naming clarifications and definitive structural assignments. J Nat Prod. 2021;84(10):2644\u201363. https:\/\/doi.org\/10.1021\/acs.jnatprod.1c00198.","journal-title":"J Nat Prod"},{"key":"533_CR126","first-page":"74","volume":"61","author":"C Li","year":"2021","unstructured":"Li C, Zhang Y, Wang Y, Liu Z, Yang W, Sun J, et al. The Clp protease complex as a promising target for anti-tuberculosis drug development: insights from natural product inhibitors. Curr Opin Chem Biol. 2021;61:74\u201381.","journal-title":"Curr Opin Chem Biol"},{"key":"533_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.961921","volume":"13","author":"ZT Laughlin","year":"2022","unstructured":"Laughlin ZT, Conn GL. Tuberactinomycin antibiotics: biosynthesis, anti-mycobacterial action, and mechanisms of resistance. Front Microbiol. 2022;13: 961921. https:\/\/doi.org\/10.3389\/fmicb.2022.961921.","journal-title":"Front Microbiol"},{"key":"533_CR128","doi-asserted-by":"publisher","first-page":"698","DOI":"10.7164\/antibiotics.50.698","volume":"50","author":"BK Morse","year":"1997","unstructured":"Morse BK, Brown MS, Gagne JW, McArthur HA, McCormick EL, Murphy TK, et al. Production of tuberactinamine A by Streptomyces griseoverticillatus var. tuberacticus NRRL 3482 fed with (S)-2-aminoethyl-L-cysteine. J Antibiot. 1997;50:698\u2013700. https:\/\/doi.org\/10.7164\/antibiotics.50.698.","journal-title":"J Antibiot"},{"issue":"9","key":"533_CR129","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0960-894X(97)00186-8","volume":"7","author":"JP Dirlam","year":"1997","unstructured":"Dirlam JP, Belton AM, Birsner NC, Brooks RR, Chang SP, Chandrasekaran RY, et al. Cyclic homopentapeptides 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella. Bioorg Med Chem Lett. 1997;7(9):1139\u201344. https:\/\/doi.org\/10.1016\/S0960-894X(97)00186-8.","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"533_CR130","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0960-894X(97)00188-1","volume":"7","author":"RG Linde","year":"1997","unstructured":"Linde RG, Birsner NC, Chandrasekaran RY, Clancy J, Howe RJ, Lyssikatos JP, et al. Cyclic homopentapeptides 3. Synthetic modifications to the capreomycins and tuberactinomycins: compounds with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci. Bioorg Med Chem Lett. 1997;7(9):1149\u201352. https:\/\/doi.org\/10.1016\/S0960-894X(97)00188-1.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"533_CR131","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1039\/c1np00041a","volume":"28","author":"AJ Oelke","year":"2011","unstructured":"Oelke AJ, France DJ, Hofmann T, Wuitschik G, Ley SV. Piperazic acid-containing natural products: isolation, biological relevance and total synthesis. Nat Prod Rep. 2011;28(8):1445\u201371. https:\/\/doi.org\/10.1039\/c1np00041a.","journal-title":"Nat Prod Rep"},{"issue":"1","key":"533_CR132","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1080\/21505594.2022.2138009","volume":"13","author":"SM Jeon","year":"2022","unstructured":"Jeon SM, Kim YJ, Nguyen TQ, Cui J, Thi Bich Hanh B, Silwal P, et al. Ohmyungsamycin promotes M1-like inflammatory responses to enhance host defence against Mycobacteroides abscessus infections. Virulence. 2022;13(1):1966\u201384. https:\/\/doi.org\/10.1080\/21505594.2022.2138009.","journal-title":"Virulence"},{"issue":"4","key":"533_CR133","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/BF01975121","volume":"36","author":"F Benazet","year":"1980","unstructured":"Benazet F, Cartier M, Florent JC, Godard C, Jung G, Lunel J, et al. Nosiheptide, a sulfur-containing peptide antibiotic isolated from Streptomyces actuosus 40037. Experientia. 1980;36(4):414\u20136. https:\/\/doi.org\/10.1007\/BF01975121.","journal-title":"Experientia"},{"issue":"12","key":"533_CR134","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ja.2012.77","volume":"65","author":"NM Haste","year":"2012","unstructured":"Haste NM, Thienphrapa W, Tran DN, Loesgen S, Sun P, Nam SJ, et al. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. J Antibiot. 2012;65(12):593\u20138. https:\/\/doi.org\/10.1038\/ja.2012.77.","journal-title":"J Antibiot"},{"issue":"18","key":"533_CR135","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/cbic.201200584","volume":"13","author":"Y Xie","year":"2012","unstructured":"Xie Y, Wang B, Liu J, Zhou J, Ma J, Huang H, Ju J. Identification of the biosynthetic gene cluster and regulatory cascade for the synergistic antibacterial antibiotics griseoviridin and viridogrisein in Streptomyces griseoviridis. ChemBioChem. 2012;13(18):2745\u201357. https:\/\/doi.org\/10.1002\/cbic.201200584.","journal-title":"ChemBioChem"},{"issue":"3","key":"533_CR136","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.synbio.2024.03.014","volume":"9","author":"S Jin","year":"2024","unstructured":"Jin S, Chen H, Zhang J, Lin Z, Qu X, Jia X, et al. Analyzing and engineering of the biosynthetic pathway of mollemycin A for enhancing its production. Synth Syst Biotechnol. 2024;9(3):445\u201352. https:\/\/doi.org\/10.1016\/j.synbio.2024.03.014.","journal-title":"Synth Syst Biotechnol"},{"issue":"3","key":"533_CR137","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01773-18","volume":"63","author":"ZG Khalil","year":"2019","unstructured":"Khalil ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, Hoang HN, Reiling N, Hillemann D, et al. Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2019;63(3): e01773-18. https:\/\/doi.org\/10.1128\/AAC.01773-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"533_CR138","doi-asserted-by":"publisher","first-page":"e00465","DOI":"10.1128\/spectrum.00465-23","volume":"11","author":"RF Rollo","year":"2023","unstructured":"Rollo RF, Mori G, Hill TA, Hillemann D, Niemann S, Homolka S, et al. Wollamide cyclic hexapeptides synergize with established and new tuberculosis antibiotics in targeting Mycobacterium tuberculosis. Microbiol Spectr. 2023;11(4):e00465-e523. https:\/\/doi.org\/10.1128\/spectrum.00465-23.","journal-title":"Microbiol Spectr"},{"issue":"Pt 5","key":"533_CR139","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1107\/S2059798320004027","volume":"76","author":"NM Wolf","year":"2020","unstructured":"Wolf NM, Lee H, Zagal D, Nam JW, Oh DC, Lee H, et al. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions. Acta Crystallogr D Struct Biol. 2020;76(Pt 5):458\u201371. https:\/\/doi.org\/10.1107\/S2059798320004027.","journal-title":"Acta Crystallogr D Struct Biol"},{"issue":"26","key":"533_CR140","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1002\/anie.201101740","volume":"50","author":"EK Schmitt","year":"2011","unstructured":"Schmitt EK, Riwanto M, Sambandamurthy V, Roggo S, Miault C, Zwingelstein C, et al. The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. Angew Chem Int Ed Engl. 2011;50(26):5889\u201391. https:\/\/doi.org\/10.1002\/anie.201101740.","journal-title":"Angew Chem Int Ed Engl"},{"key":"533_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2024.102594","volume":"151","author":"MT Stevens","year":"2025","unstructured":"Stevens MT, Hawkins PME, Wang T, Payne RJ, Britton WJ. Analogue of the natural product ecumicin causes sustained growth inhibition of Mycobacterium tuberculosis under multiple growth conditions. Tuberculosis. 2025;151: 102594. https:\/\/doi.org\/10.1016\/j.tube.2024.102594.","journal-title":"Tuberculosis"},{"key":"533_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102298","volume":"138","author":"J Hong","year":"2023","unstructured":"Hong J, Duc NM, Jeong BC, Cho S, Shetye G, Cao J, et al. Identification of the inhibitory mechanism of ecumicin and rufomycin 4\u20137 on the proteolytic activity of Mycobacterium tuberculosis ClpC1\/ClpP1\/ClpP2 complex. Tuberculosis. 2023;138: 102298. https:\/\/doi.org\/10.1016\/j.tube.2022.102298.","journal-title":"Tuberculosis"},{"issue":"4","key":"533_CR143","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1021\/acs.orglett.7b03967","volume":"20","author":"PME Hawkins","year":"2018","unstructured":"Hawkins PME, Giltrap AM, Nagalingam G, Britton WJ, Payne RJ. Total synthesis of Ecumicin. Org Lett. 2018;20(4):1019\u201322. https:\/\/doi.org\/10.1021\/acs.orglett.7b03967.","journal-title":"Org Lett"},{"issue":"1","key":"533_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32774-3","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Lin S, Fang Q, Gyampoh R, Lu Z, Gao Y, et al. A ribosomally synthesised and post-translationally modified peptide containing a \u03b2-enamino acid and a macrocyclic motif. Nat Commun. 2022;13(1): 5044. https:\/\/doi.org\/10.1038\/s41467-022-32774-3.","journal-title":"Nat Commun"},{"issue":"10","key":"533_CR145","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1007\/s00253-019-09771-6","volume":"103","author":"S Zhu","year":"2019","unstructured":"Zhu S, Su Y, Shams S, Feng Y, Tong Y, Zheng G. Lassomycin and lariatin lasso peptides as suitable antibiotics for combating mycobacterial infections: current state of biosynthesis and perspectives for production. Appl Microbiol Biotechnol. 2019;103(10):3931\u201340. https:\/\/doi.org\/10.1007\/s00253-019-09771-6.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"19","key":"533_CR146","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1039\/c6ob00631k","volume":"14","author":"S Lear","year":"2016","unstructured":"Lear S, Munshi T, Hudson AS, Hatton C, Clardy J, Mosely JA, et al. Total chemical synthesis of lassomycin and lassomycin-amide. Org Biomol Chem. 2016;14(19):4534\u201341. https:\/\/doi.org\/10.1039\/c6ob00631k.","journal-title":"Org Biomol Chem"},{"issue":"3","key":"533_CR147","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod. 2020;83(3):770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285.","journal-title":"J Nat Prod"},{"issue":"3","key":"533_CR148","first-page":"140","volume":"6","author":"K Maeda","year":"1953","unstructured":"Maeda K, Kosaka H, Okami Y, Umezawa H. A new antibiotic, pyridomycin. J Antibiot. 1953;6(3):140.","journal-title":"J Antibiot"},{"issue":"6","key":"533_CR149","doi-asserted-by":"publisher","first-page":"e02035","DOI":"10.1128\/AEM.02035-21","volume":"88","author":"T Huang","year":"2022","unstructured":"Huang T, Zhou Z, Wei M, Chen L, Xiao Z, Deng Z, et al. Characterization of pyridomycin B reveals the formation of functional groups in antimycobacterial pyridomycin. Appl Environ Microbiol. 2022;88(6):e02035-e2121. https:\/\/doi.org\/10.1128\/AEM.02035-21.","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"533_CR150","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nchembio.1405","volume":"10","author":"RC Hartkoorn","year":"2014","unstructured":"Hartkoorn RC, Pojer F, Read JA, Gingell H, Neres J, Horlacher OP, et al. Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA. Nat Chem Biol. 2014;10(2):96\u20138. https:\/\/doi.org\/10.1038\/nchembio.1405.","journal-title":"Nat Chem Biol"},{"issue":"Jan 20","key":"533_CR151","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/acschembio.2c00773","volume":"18","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Yang X, Huang T, Zheng J, Deng Z, Dai S, et al. Bifunctional NadC homologue PyrZ catalyzes nicotinic acid formation in pyridomycin biosynthesis. ACS Chem Biol. 2023;18(Jan 20):141\u201350. https:\/\/doi.org\/10.1021\/acschembio.2c00773.","journal-title":"ACS Chem Biol"},{"issue":"7","key":"533_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.877","volume":"11","author":"A Wang","year":"2023","unstructured":"Wang A, Ma X, Wei F, Li Y, Liu Q, Zhang H. Evidence on the therapeutic role of thiolutin in imiquimod-induced psoriasis-like skin inflammation in mice. Immun Inflamm Dis. 2023;11(7): e877. https:\/\/doi.org\/10.1002\/iid3.877.","journal-title":"Immun Inflamm Dis"},{"issue":"7","key":"533_CR153","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nchembio.2370","volume":"13","author":"L Lauinger","year":"2017","unstructured":"Lauinger L, Li J, Shostak A, Cemel IA, Ha N, Zhang Y, et al. Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases. Nat Chem Biol. 2017;13(7):709\u201314. https:\/\/doi.org\/10.1038\/nchembio.2370.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"533_CR154","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/nar\/gkad1258","volume":"52","author":"C Qiu","year":"2024","unstructured":"Qiu C, Arora P, Malik I, Laperuta AJ, Pavlovic EM, Ugochukwu S, et al. Thiolutin has complex effects in vivo but is a direct inhibitor of RNA polymerase II in vitro. Nucleic Acids Res. 2024;52(5):2546\u201364. https:\/\/doi.org\/10.1093\/nar\/gkad1258.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"533_CR155","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1039\/c3np70106a","volume":"31","author":"B Li","year":"2014","unstructured":"Li B, Wever WJ, Walsh CT, Bowers AA. Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics. Nat Prod Rep. 2014;31(7):905\u201323. https:\/\/doi.org\/10.1039\/c3np70106a.","journal-title":"Nat Prod Rep"},{"issue":"38","key":"533_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo6918","volume":"8","author":"YU Tittes","year":"2022","unstructured":"Tittes YU, Herbst DA, Martin SFX, Munoz-Hernandez H, Jakob RP, Maier T. The structure of a polyketide synthase bimodule core. Sci Adv. 2022;8(38): eabo6918. https:\/\/doi.org\/10.1126\/sciadv.abo6918.","journal-title":"Sci Adv"},{"issue":"26","key":"533_CR157","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1002\/anie.200806121","volume":"48","author":"C Hertweck","year":"2009","unstructured":"Hertweck C. The biosynthetic logic of polyketide diversity. Angew Chem Int Ed Engl. 2009;48(26):4688\u2013716. https:\/\/doi.org\/10.1002\/anie.200806121.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"533_CR158","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/ismej.2015.263","volume":"10","author":"GS Kohli","year":"2016","unstructured":"Kohli GS, John U, Van Dolah FM, Murray SA. Evolutionary distinctiveness of fatty acid and polyketide synthesis in eukaryotes. ISME J. 2016;10(8):1877\u201390. https:\/\/doi.org\/10.1038\/ismej.2015.263.","journal-title":"ISME J"},{"key":"533_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.148878","volume":"795","author":"K Anestis","year":"2021","unstructured":"Anestis K, Kohli GS, Wohlrab S, Varga E, Larsen TO, Hansen PJ, et al. Polyketide synthase genes and molecular trade-offs in the ichthyotoxic species Prymnesium parvum. Sci Total Environ. 2021;795: 148878. https:\/\/doi.org\/10.1016\/j.scitotenv.2021.148878.","journal-title":"Sci Total Environ"},{"issue":"1","key":"533_CR160","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1021\/acs.jnatprod.7b00859","volume":"81","author":"Y Hu","year":"2018","unstructured":"Hu Y, Wang M, Wu C, Tan Y, Li J, Hao X, et al. Identification and proposed relative and absolute configurations of niphimycins C-E from the marine-derived Streptomyces sp. IMB7-145 by genomic analysis. J Nat Prod. 2018;81(1):178\u201387. https:\/\/doi.org\/10.1021\/acs.jnatprod.7b00859.","journal-title":"J Nat Prod"},{"issue":"4","key":"533_CR161","doi-asserted-by":"publisher","first-page":"408","DOI":"10.7164\/antibiotics.29.408","volume":"29","author":"Y Mikami","year":"1976","unstructured":"Mikami Y, Yokoyama K, Omi A, Arai T. Identification of producer and biological activities of new antibiotics, mimosamycin and chlorocarcins. J Antibiot. 1976;29(4):408\u201314. https:\/\/doi.org\/10.7164\/antibiotics.29.408.","journal-title":"J Antibiot"},{"issue":"16","key":"533_CR162","doi-asserted-by":"publisher","first-page":"11011","DOI":"10.1021\/acs.joc.0c02492","volume":"86","author":"OG Mohamed","year":"2021","unstructured":"Mohamed OG, Khalil ZG, Salim AA, Cui H, Blumenthal A, Capon RJ. Lincolnenins A-D: isomeric bactericidal bianthracenes from Streptomyces lincolnensis. J Org Chem. 2021;86(16):11011\u20138. https:\/\/doi.org\/10.1021\/acs.joc.0c02492.","journal-title":"J Org Chem"},{"key":"533_CR163","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.micres.2017.12.004","volume":"207","author":"A Hussain","year":"2018","unstructured":"Hussain A, Rather MA, Dar MS, Dangroo NA, Aga MA, Qayum A, et al. Streptomyces puniceus strain AS13., production, characterization and evaluation of bioactive metabolites: a new face of dinactin as an antitumor antibiotic. Microbiol Res. 2018;207:196\u2013202. https:\/\/doi.org\/10.1016\/j.micres.2017.12.004.","journal-title":"Microbiol Res"},{"issue":"Apr 24","key":"533_CR164","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1021\/acs.jnatprod.5b00095","volume":"78","author":"ZG Khalil","year":"2015","unstructured":"Khalil ZG, Raju R, Piggott AM, Salim AA, Blumenthal A, Capon RJ. Aranciamycins I and J, antimycobacterial anthracyclines from an Australian marine-derived Streptomyces sp. J Nat Prod. 2015;78(Apr 24):949\u201352. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b00095.","journal-title":"J Nat Prod"},{"issue":"2","key":"533_CR165","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00253-016-7804-1","volume":"101","author":"K Supong","year":"2017","unstructured":"Supong K, Sripreechasak P, Tanasupawat S, Danwisetkanjana K, Rachtawee P, Pittayakhajonwut P. Investigation on antimicrobial agents of the terrestrial Streptomyces sp. BCC71188. Appl Microbiol Biotechnol. 2017;101(2):533\u201343. https:\/\/doi.org\/10.1007\/s00253-016-7804-1.","journal-title":"Appl Microbiol Biotechnol"},{"key":"533_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00199","volume":"7","author":"W Moreira","year":"2016","unstructured":"Moreira W, Aziz DB, Dick T. Boromycin kills mycobacterial persisters without detectable resistance. Front Microbiol. 2016;7: 199. https:\/\/doi.org\/10.3389\/fmicb.2016.00199.","journal-title":"Front Microbiol"},{"issue":"1","key":"533_CR167","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ja.2013.115","volume":"67","author":"Z Lin","year":"2014","unstructured":"Lin Z, Koch M, Pond CD, Mabeza G, Seronay RA, Concepcion GP, et al. Structure and activity of lobophorins from a turrid mollusk-associated Streptomyces sp. J Antibiot. 2014;67(1):121\u20136. https:\/\/doi.org\/10.1038\/ja.2013.115.","journal-title":"J Antibiot"},{"issue":"9","key":"533_CR168","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1007\/s00253-012-4681-0","volume":"97","author":"C Chen","year":"2013","unstructured":"Chen C, Wang J, Guo H, Hou W, Yang N, Ren B, et al. Three antimycobacterial metabolites identified from a marine-derived Streptomyces sp. MS100061. Appl Microbiol Biotechnol. 2013;97(9):3885\u201392. https:\/\/doi.org\/10.1007\/s00253-012-4681-0.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"533_CR169","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s11033-018-4424-0","volume":"45","author":"M Trenado-Uribe","year":"2018","unstructured":"Trenado-Uribe M, Silva-Miranda M, Rivero-Cruz JF, Rodr\u00edguez-Pe\u00f1a K, Espitia-Pinz\u00f3n CI, Rodr\u00edguez-Sanoja R, et al. Antimycobacterial activity of an anthracycline produced by an endophyte isolated from Amphipterygium adstringens. Mol Biol Rep. 2018;45(6):2563\u201370. https:\/\/doi.org\/10.1007\/s11033-018-4424-0.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"533_CR170","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41429-020-0290-9","volume":"73","author":"N Koyama","year":"2020","unstructured":"Koyama N, Shigeno S, Kanamoto A, Tomoda H. Steffimycin E, a new anti-mycobacterial agent against Mycobacterium avium complex, produced by Streptomyces sp. OPMA02852. J Antibiot. 2020;73(8):581\u20134. https:\/\/doi.org\/10.1038\/s41429-020-0290-9.","journal-title":"J Antibiot"},{"issue":"49","key":"533_CR171","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1016\/j.tetlet.2015.10.098","volume":"56","author":"C Intaraudom","year":"2015","unstructured":"Intaraudom C, Bunbamrung N, Dramae A, Danwisetkanjana K, Rachtawee P, Pittayakhajonwut P. Antimalarial and antimycobacterial agents from Streptomyces sp. BCC27095. Tetrahedron Lett. 2015;56(49):6875\u20137. https:\/\/doi.org\/10.1016\/j.tetlet.2015.10.098.","journal-title":"Tetrahedron Lett"},{"issue":"2","key":"533_CR172","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/molecules20022576","volume":"20","author":"MA Yassien","year":"2015","unstructured":"Yassien MA, Abdallah HM, El-Halawany AM, Jiman-Fatani AA. Anti-tuberculous activity of treponemycin produced by a Streptomyces strain MS-6-6 isolated from Saudi Arabia. Molecules. 2015;20(2):2576\u201390. https:\/\/doi.org\/10.3390\/molecules20022576.","journal-title":"Molecules"},{"issue":"58","key":"533_CR173","doi-asserted-by":"publisher","first-page":"36335","DOI":"10.1039\/C7RA05576E","volume":"7","author":"B Muralikrishnan","year":"2017","unstructured":"Muralikrishnan B, Dan VM, Vinodh JS, Jamsheena V, Ramachandran R, Thomas S, et al. Anti-microbial activity of chrysomycin A produced by Streptomyces sp. against Mycobacterium tuberculosis. RSC Adv. 2017;7(58):36335\u20139. https:\/\/doi.org\/10.1039\/C7RA05576E.","journal-title":"RSC Adv"},{"issue":"3","key":"533_CR174","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.phytol.2012.06.015","volume":"5","author":"K Supong","year":"2012","unstructured":"Supong K, Thawai C, Suwanborirux K, Choowong W. Antimalarial and antitubercular C-glycosylated benz[\u03b1]anthraquinones from the marine-derived Streptomyces sp. BCC45596. Phytochem Lett. 2012;5(3):651\u20136. https:\/\/doi.org\/10.1016\/j.phytol.2012.06.015.","journal-title":"Phytochem Lett"},{"issue":"2","key":"533_CR175","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41429-021-00494-3","volume":"75","author":"A Hikima","year":"2022","unstructured":"Hikima A, Asamizu S, Onaka H, Zhang H, Tomoda H, Koyama N. Kimidinomycin, a new antibiotic against Mycobacterium avium complex, produced by Streptomyces sp. KKTA-0263. J Antibiot. 2022;75(2):72\u20136. https:\/\/doi.org\/10.1038\/s41429-021-00494-3.","journal-title":"J Antibiot"},{"issue":"4","key":"533_CR176","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acsinfecdis.5b00005","volume":"1","author":"MW Mullowney","year":"2015","unstructured":"Mullowney MW, Hwang CH, Newsome AG, Wei X, Tanouye U, Wan B, et al. Diaza-anthracene antibiotics from a freshwater-derived actinomycete with selective antibacterial activity toward Mycobacterium tuberculosis. ACS Infect Dis. 2015;1(4):168\u201374. https:\/\/doi.org\/10.1021\/acsinfecdis.5b00005.","journal-title":"ACS Infect Dis"},{"key":"533_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2020.112275","volume":"172","author":"N Bunbamrung","year":"2020","unstructured":"Bunbamrung N, Intaraudom C, Dramae A, Thawai C, Tadtong S, Auncharoen P, et al. Antibacterial, antitubercular, antimalarial and cytotoxic substances from the endophytic Streptomyces sp. TBRC7642. Phytochemistry. 2020;172: 112275. https:\/\/doi.org\/10.1016\/j.phytochem.2020.112275.","journal-title":"Phytochemistry"},{"issue":"4","key":"533_CR178","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.resmic.2016.01.004","volume":"167","author":"K Supong","year":"2016","unstructured":"Supong K, Thawai C, Choowong W, Kittiwongwattana C, Thanaboripat D, Laosinwattana C, et al. Antimicrobial compounds from endophytic Streptomyces sp. BCC72023 isolated from rice (Oryza sativa L.). Res Microbiol. 2016;167(4):290\u20138. https:\/\/doi.org\/10.1016\/j.resmic.2016.01.004.","journal-title":"Res Microbiol"},{"issue":"1","key":"533_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/md18010022","volume":"18","author":"D Carretero-Molina","year":"2019","unstructured":"Carretero-Molina D, Ortiz-L\u00f3pez FJ, Mart\u00edn J, Oves-Costales D, D\u00edaz C, de la Cruz M, et al. New napyradiomycin analogues from Streptomyces sp. strain CA-271078. Mar Drugs. 2019;18(1): 22. https:\/\/doi.org\/10.3390\/md18010022.","journal-title":"Mar Drugs"},{"issue":"13","key":"533_CR180","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1016\/j.bmc.2015.04.033","volume":"23","author":"M Arai","year":"2015","unstructured":"Arai M, Kamiya K, Pruksakorn P, Sumii Y, Kotoku N, Joubert JP, et al. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp. Bioorg Med Chem. 2015;23(13):3534\u201341. https:\/\/doi.org\/10.1016\/j.bmc.2015.04.033.","journal-title":"Bioorg Med Chem"},{"issue":"21","key":"533_CR181","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1080\/14786419.2023.2263902","volume":"38","author":"K Supong","year":"2024","unstructured":"Supong K, Bunbamrung N, Tanasupawat S, Auncharoen P, Nithithanasilp S, Rachtawee P, et al. Frenolicins H and I from the caterpillar-associated Streptomyces sp. TBRC17107. Nat Prod Res. 2024;38(21):3773\u201382. https:\/\/doi.org\/10.1080\/14786419.2023.2263902.","journal-title":"Nat Prod Res"},{"issue":"2","key":"533_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/md17020114","volume":"17","author":"AF Bra\u00f1a","year":"2019","unstructured":"Bra\u00f1a AF, Sarmiento-Vizca\u00edno A, P\u00e9rez-Victoria I, Mart\u00edn J, Otero L, Palacios-Guti\u00e9rrez JJ, et al. Desertomycin G, a new antibiotic with activity against Mycobacterium tuberculosis and human breast tumor cell lines produced by Streptomyces althioticus MSM3, isolated from the Cantabrian Sea intertidal macroalgae Ulva sp. Mar Drugs. 2019;17(2): 114. https:\/\/doi.org\/10.3390\/md17020114.","journal-title":"Mar Drugs"},{"issue":"1","key":"533_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65702-0","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Reheman A, Wan C. Discovery of anti-Mycobacterium tuberculosis desertomycins from Streptomyces flavofungini TRM90047 based on genome mining and HSQC-TOCSY. Sci Rep. 2024;14(1): 17006. https:\/\/doi.org\/10.1038\/s41598-024-65702-0.","journal-title":"Sci Rep"},{"issue":"2","key":"533_CR184","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4014\/jmb.1209.09038","volume":"23","author":"YJ Kwon","year":"2013","unstructured":"Kwon YJ, Sohn MJ, Oh T, Cho SN, Kim CJ, Kim WG. Panosialins, inhibitors of enoyl-ACP reductase from Streptomyces sp. AN1761. J Microbiol Biotechnol. 2013;23(2):184\u20138. https:\/\/doi.org\/10.4014\/jmb.1209.09038.","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"533_CR185","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/acs.jnatprod.1c00703","volume":"85","author":"TH Huynh","year":"2022","unstructured":"Huynh TH, Lee J, Moon DH, Nguyen TQ, Son S, Hwang S, et al. Gwanakosides A and B, 6-deoxy-\u03b1-l-talopyranose-bearing aromatic metabolites from a Streptomyces sp. and coculture with Pandoraea sp. J Nat Prod. 2022;85(1):83\u201390. https:\/\/doi.org\/10.1021\/acs.jnatprod.1c00703.","journal-title":"J Nat Prod"},{"issue":"10","key":"533_CR186","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41429-022-00554-2","volume":"75","author":"C Boonlarppradab","year":"2022","unstructured":"Boonlarppradab C, Saepua S, Pruksatrakul T, Choowong W, Rachtawee P, Suriyachadkun C. Benzothioate Glycoside from a terrestrial Streptomyces sp. TBRC 11511 from Thailand. J Antibiot. 2022;75(10):583\u20138. https:\/\/doi.org\/10.1038\/s41429-022-00554-2.","journal-title":"J Antibiot"},{"issue":"17","key":"533_CR187","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1007\/s00253-016-7406-y","volume":"100","author":"P Huang","year":"2016","unstructured":"Huang P, Xie F, Ren B, Wang Q, Wang J, Wang Q, et al. Anti-MRSA and anti-TB metabolites from marine-derived Verrucosispora sp. MS100047. Appl Microbiol Biotechnol. 2016;100(17):7437\u201347. https:\/\/doi.org\/10.1007\/s00253-016-7406-y.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"533_CR188","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1021\/acs.orglett.1c00847","volume":"23","author":"JS An","year":"2021","unstructured":"An JS, Shin B, Kim TH, Hwang S, Shin YH, Cui J, et al. Dumulmycin, an antitubercular bicyclic macrolide from a riverine sediment-derived Streptomyces sp. Org Lett. 2021;23(9):3359\u201363. https:\/\/doi.org\/10.1021\/acs.orglett.1c00847.","journal-title":"Org Lett"},{"issue":"5","key":"533_CR189","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41429-024-00710-w","volume":"77","author":"S Shigeno","year":"2024","unstructured":"Shigeno S, Kadowaki M, Nagai K, Hosoda K, Terahara T, Nishimura T, et al. New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239. J Antibiot. 2024;77(5):265\u201371. https:\/\/doi.org\/10.1038\/s41429-024-00710-w.","journal-title":"J Antibiot"},{"issue":"7","key":"533_CR190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006306","volume":"4","author":"AK Brown","year":"2009","unstructured":"Brown AK, Taylor RC, Bhatt A, F\u00fctterer K, Besra GS. Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases. PLoS ONE. 2009;4(7): e6306. https:\/\/doi.org\/10.1371\/journal.pone.0006306.","journal-title":"PLoS ONE"},{"issue":"7","key":"533_CR191","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jobm.201200045","volume":"53","author":"HY Kim","year":"2013","unstructured":"Kim HY, Kim JD, Hong JW, Ham JH, Kim BS. Identification of antifungal niphimycin from Streptomyces sp. KP6107 by screening based on adenylate kinase assay. J Basic Microbiol. 2013;53(7):581\u20139. https:\/\/doi.org\/10.1002\/jobm.201200045.","journal-title":"J Basic Microbiol"},{"issue":"3","key":"533_CR192","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1021\/jo990767d","volume":"65","author":"B Kesteleyn","year":"2000","unstructured":"Kesteleyn B, De Kimpe N. Synthesis of mimosamycin. J Org Chem. 2000;65(3):635\u20139. https:\/\/doi.org\/10.1021\/jo990767d.","journal-title":"J Org Chem"},{"issue":"9","key":"533_CR193","first-page":"3763","volume":"101","author":"Y Li","year":"2017","unstructured":"Li Y, Sun Y, Hong H. Genomic insights into lincolnemin biosynthesis in Streptomyces lincolnensis. Appl Microbiol Biotechnol. 2017;101(9):3763\u201371.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"533_CR194","first-page":"158","volume":"57","author":"H Ogawa","year":"2004","unstructured":"Ogawa H, Fukuda D, Tanaka N. Isolation and structure of lincolnemin, a new aromatic antibiotic from Streptomyces sp. J Antibiot. 2004;57(3):158\u201362.","journal-title":"J Antibiot"},{"key":"533_CR195","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF02884062","volume":"36","author":"J Jizba","year":"1991","unstructured":"Jizba J, Sedmera P, Zima J, Beran M, Blumauerov\u00e1 M, Kandybin NV, et al. Macrotetrolide antibiotics produced by Streptomyces globisporus. Folia Microbiol. 1991;36:437\u201343. https:\/\/doi.org\/10.1007\/BF02884062.","journal-title":"Folia Microbiol"},{"issue":"23","key":"533_CR196","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1016\/j.bmcl.2015.07.103","volume":"25","author":"LH Rakotondraibe","year":"2015","unstructured":"Rakotondraibe LH, Rasolomampianina R, Park HY, Li J, Slebodnik C, Brodie PJ, et al. Antiproliferative and antiplasmodial compounds from selected Streptomyces species. Bioorg Med Chem Lett. 2015;25(23):5646\u20139. https:\/\/doi.org\/10.1016\/j.bmcl.2015.07.103.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"533_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007643","volume":"13","author":"HE Ortega","year":"2019","unstructured":"Ortega HE, Ferreira LLG, Melo WGP, Oliveira ALL, Ramos Alvarenga RF, Lopes NP, et al. Antifungal compounds from Streptomyces associated with attine ants also inhibit Leishmania donovani. PLoS Negl Trop Dis. 2019;13(8): e0007643. https:\/\/doi.org\/10.1371\/journal.pntd.0007643.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"533_CR198","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121845","volume":"11","author":"A Rawangkan","year":"2022","unstructured":"Rawangkan A, Wongsirisin P, Pook-In G, Siriphap A, Yosboonruang A, Kiddee A, et al. Dinactin: a new antitumor antibiotic with cell cycle progression and cancer stemness inhibiting activities in lung cancer. Antibiotics. 2022;11(12): 1845. https:\/\/doi.org\/10.3390\/antibiotics11121845.","journal-title":"Antibiotics"},{"key":"533_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2020.126548","volume":"240","author":"K Zhang","year":"2020","unstructured":"Zhang K, Gu L, Zhang Y, Liu Z, Li X. Dinactin from a new producer, Streptomyces badius gz-8, and its antifungal activity against the rubber anthracnose fungus Colletotrichum gloeosporioides. Microbiol Res. 2020;240: 126548. https:\/\/doi.org\/10.1016\/j.micres.2020.126548.","journal-title":"Microbiol Res"},{"issue":"23","key":"533_CR200","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235812","volume":"14","author":"J Ji","year":"2022","unstructured":"Ji J, Wang K, Meng X, Zhong H, Li X, Zhao H, et al. Elaiophylin inhibits tumorigenesis of human lung adenocarcinoma by inhibiting mitophagy via suppression of SIRT1\/Nrf2 signaling. Cancers. 2022;14(23): 5812. https:\/\/doi.org\/10.3390\/cancers14235812.","journal-title":"Cancers"},{"key":"533_CR201","first-page":"207","volume":"7","author":"FM Arcamone","year":"1959","unstructured":"Arcamone FM, Bertazzoli C, Ghione M, Scotti T. Melanosporin and elaiophylin, new antibiotics from Streptomyces melanosporus (sive melonsporofaciens) n. sp. G Microbiol. 1959;7:207\u201316.","journal-title":"G Microbiol"},{"issue":"4","key":"533_CR202","first-page":"245","volume":"6","author":"L Sang-Yong","year":"1996","unstructured":"Sang-Yong L, Kim MS, Kim HS, Kim YH, Hong SD, Lee JJ. Structure determination and biological activities of elaiophylin produced by Streptomyces sp. MCY-846. J Microbiol Biotechnol. 1996;6(4):245\u20139.","journal-title":"J Microbiol Biotechnol"},{"issue":"2","key":"533_CR203","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7164\/antibiotics.53.158","volume":"53","author":"A Fang","year":"2000","unstructured":"Fang A, Wong GK, Demain AL. Enhancement of the antifungal activity of rapamycin by the coproduced elaiophylin and nigericin. J Antibiot. 2000;53(2):158\u201362. https:\/\/doi.org\/10.7164\/antibiotics.53.158.","journal-title":"J Antibiot"},{"issue":"4","key":"533_CR204","first-page":"272","volume":"7","author":"L Sang-Yong","year":"1997","unstructured":"Sang-Yong L, Kim HS, Kim YH, Han SB, Kim HM, Hong SD, et al. Immunosuppressive activity of elaiophylins. J Microbiol Biotechnol. 1997;7(4):272\u20137.","journal-title":"J Microbiol Biotechnol"},{"issue":"21","key":"533_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24213840","volume":"24","author":"M Gui","year":"2019","unstructured":"Gui M, Zhang MX, Wu WH, Sun P. Natural occurrence, bioactivity and biosynthesis of elaiophylin analogues. Molecules. 2019;24(21): 3840. https:\/\/doi.org\/10.3390\/molecules24213840.","journal-title":"Molecules"},{"key":"533_CR206","unstructured":"Gan M, Liu D, Yuan Z, Li U, Zhou X, Wang H, et al. Elaiophylin derivative and the application in antimicrobial agent and resistance M. tuberculosis infection thereof. CN103665071B. Instituto de Biotecnologia Medicinal da Academia Chinesa de Ci\u00eancias M\u00e9dicas e da Universidade M\u00e9dica da Uni\u00e3o de Pequim; 2016. https:\/\/patents.google.com\/patent\/CN103665071B\/en (Accessed 15 May 2025)."},{"key":"533_CR207","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/hlca.19710540624","volume":"54","author":"JD Dunitz","year":"1971","unstructured":"Dunitz JD, Hawley DM, Miklos D, White DN, Berlin Y, Marusi\u0107 R, et al. Structure of boromycin. Helv Chim Acta. 1971;54:1709\u201313. https:\/\/doi.org\/10.1002\/hlca.19710540624.","journal-title":"Helv Chim Acta"},{"issue":"6","key":"533_CR208","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1271\/bbb.60.1036","volume":"60","author":"J Kohno","year":"1996","unstructured":"Kohno J, Kawahata T, Otake T, Morimoto M, Mori H, Ueba N, et al. Boromycin, an anti-HIV antibiotic. Biosci Biotechnol Biochem. 1996;60(6):1036\u20137. https:\/\/doi.org\/10.1271\/bbb.60.1036.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"4","key":"533_CR209","doi-asserted-by":"publisher","first-page":"e01278","DOI":"10.1128\/AAC.01278-20","volume":"65","author":"J Abenoja","year":"2021","unstructured":"Abenoja J, Cotto-Rosario A, O\u2019Connor R. Boromycin has potent anti-Toxoplasma and anti-Cryptosporidium activity. Antimicrob Agents Chemother. 2021;65(4):e01278-e1320. https:\/\/doi.org\/10.1128\/AAC.01278-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"533_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28083597","volume":"28","author":"J Shi","year":"2023","unstructured":"Shi J, Peng D, Peng FF, Zhang QB, Duan YW, Huang Y. The isolation and structure elucidation of spirotetronate lobophorins A, B, and H8 from Streptomyces sp. CB09030 and their biosynthetic gene cluster. Molecules. 2023;28(8): 3597. https:\/\/doi.org\/10.3390\/molecules28083597.","journal-title":"Molecules"},{"issue":"3","key":"533_CR211","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30030586","volume":"30","author":"X Chen","year":"2025","unstructured":"Chen X, Du Y, Ma Y, Liu P, Chen Y. Antimicrobial lobophorins from endophytic strain Streptomyces sp. R6 obtained from Azadirachta indica. Molecules. 2025;30(3): 586. https:\/\/doi.org\/10.3390\/molecules30030586.","journal-title":"Molecules"},{"key":"533_CR212","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hlca.19670500303","volume":"50","author":"W Keller-Schierlein","year":"1967","unstructured":"Keller-Schierlein W, Z\u00e4hner H, Meyer W. Steffimycin, a new anthracycline antibiotic. Helv Chim Acta. 1967;50:1390\u2013401.","journal-title":"Helv Chim Acta"},{"issue":"3","key":"533_CR213","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1021\/acs.orglett.6b03708","volume":"19","author":"G Wang","year":"2017","unstructured":"Wang G, Chen J, Zhu H, Rohr J. One-pot enzymatic total synthesis of presteffimycinone, an early intermediate of the anthracycline antibiotic steffimycin biosynthesis. Org Lett. 2017;19(3):540\u20133. https:\/\/doi.org\/10.1021\/acs.orglett.6b03708.","journal-title":"Org Lett"},{"issue":"6","key":"533_CR214","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1128\/AEM.00734-06","volume":"72","author":"S Gull\u00f3n","year":"2006","unstructured":"Gull\u00f3n S, Olano C, Abdelfattah MS, Bra\u00f1a AF, Rohr J, M\u00e9ndez C, et al. Isolation, characterization, and heterologous expression of the biosynthesis gene cluster for the antitumor anthracycline steffimycin. Appl Environ Microbiol. 2006;72(6):4172\u201383. https:\/\/doi.org\/10.1128\/AEM.00734-06.","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"533_CR215","first-page":"190","volume":"344","author":"R H\u00fctter","year":"1966","unstructured":"H\u00fctter R, Poralla K, Zachau HG, Z\u00e4hner H. Metabolic products of microorganisms. 5l. On the mechanism of action of borrelidin\u2014inhibition of the threonine incorporation in sRNA. Biochem Z. 1966;344(2):190\u20136.","journal-title":"Biochem Z"},{"issue":"2","key":"533_CR216","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1432-1033.1973.tb02843.x","volume":"35","author":"W Paetz","year":"1973","unstructured":"Paetz W, Nass G. Biochemical and immunological characterization of threonyl-tRNA synthetase of two borrelidin-resistant mutants of Escherichia coli K12. Eur J Biochem. 1973;35(2):331\u20137. https:\/\/doi.org\/10.1111\/j.1432-1033.1973.tb02843.x.","journal-title":"Eur J Biochem"},{"issue":"51","key":"533_CR217","doi-asserted-by":"publisher","first-page":"E5508","DOI":"10.1073\/pnas.1405994111","volume":"111","author":"EM Novoa","year":"2014","unstructured":"Novoa EM, Camacho N, Tor A, Wilkinson B, Moss S, Mar\u00edn-Garc\u00eda P, et al. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo. Proc Natl Acad Sci U S A. 2014;111(51):E5508\u201317. https:\/\/doi.org\/10.1073\/pnas.1405994111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"533_CR218","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1128\/AAC.27.2.239","volume":"27","author":"SK Singh","year":"1985","unstructured":"Singh SK, Gurusiddaiah S, Whalen JW. Treponemycin, a nitrile antibiotic active against Treponema hyodysenteriae. Antimicrob Agents Chemother. 1985;27(2):239\u201345. https:\/\/doi.org\/10.1128\/AAC.27.2.239.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"533_CR219","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1128\/jb.69.3.280-283.1955","volume":"69","author":"F Strelitz","year":"1955","unstructured":"Strelitz F, Flon H, Asheshov IN. Chrysomycin: a new antibiotic substance for bacterial viruses. J Bacteriol. 1955;69(3):280\u20133. https:\/\/doi.org\/10.1128\/jb.69.3.280-283.1955.","journal-title":"J Bacteriol"},{"issue":"9","key":"533_CR220","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.7164\/antibiotics.35.1194","volume":"35","author":"U Weiss","year":"1982","unstructured":"Weiss U, Yoshihira K, Highet RJ, White RJ, Wei TT. The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A. J Antibiot. 1982;35(9):1194\u2013201. https:\/\/doi.org\/10.7164\/antibiotics.35.1194.","journal-title":"J Antibiot"},{"key":"533_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106565","volume":"187","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu P, Chen J, Yao D, Liu Q, Zhang J, et al. Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression. Pharmacol Res. 2023;187: 106565. https:\/\/doi.org\/10.1016\/j.phrs.2022.106565.","journal-title":"Pharmacol Res"},{"issue":"6","key":"533_CR222","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/acscentsci.0c00122","volume":"6","author":"F Wu","year":"2020","unstructured":"Wu F, Zhang J, Song F, Wang S, Guo H, Wei Q, et al. Chrysomycin A derivatives for the treatment of multi-drug-resistant tuberculosis. ACS Cent Sci. 2020;6(6):928\u201338. https:\/\/doi.org\/10.1021\/acscentsci.0c00122.","journal-title":"ACS Cent Sci"},{"issue":"4","key":"533_CR223","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41429-022-00503-z","volume":"75","author":"B Muralikrishnan","year":"2022","unstructured":"Muralikrishnan B, Edison LK, Dusthackeer A, Jijimole GR, Ramachandran R, Madhavan A, et al. Chrysomycin A inhibits the topoisomerase I of Mycobacterium tuberculosis. J Antibiot. 2022;75(4):226\u201335. https:\/\/doi.org\/10.1038\/s41429-022-00503-z.","journal-title":"J Antibiot"},{"issue":"2","key":"533_CR224","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1039\/c1np00068c","volume":"29","author":"MK Kharel","year":"2012","unstructured":"Kharel MK, Pahari P, Shepherd MD, Tibrewal N, Nybo SE, Shaaban KA, Rohr J. Angucyclines: biosynthesis, mode-of-action, new natural products, and synthesis. Nat Prod Rep. 2012;29(2):264\u2013325. https:\/\/doi.org\/10.1039\/c1np00068c.","journal-title":"Nat Prod Rep"},{"issue":"10","key":"533_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/cplu.202400307","volume":"89","author":"D Vyslou\u017eilov\u00e1","year":"2024","unstructured":"Vyslou\u017eilov\u00e1 D, Kov\u00e1\u010d O. The chemistry of angucyclines. ChemPlusChem. 2024;89(10): e202400307. https:\/\/doi.org\/10.1002\/cplu.202400307.","journal-title":"ChemPlusChem"},{"issue":"9","key":"533_CR226","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/s0968-0896(00)00166-8","volume":"8","author":"A Kirschning","year":"2000","unstructured":"Kirschning A, Chen GW, Dr\u00e4ger G, Schuberth I, Tietze LF. Syntheses and biological evaluation of new glyco-modified angucyclin-antibiotics. Bioorg Med Chem. 2000;8(9):2347\u201354. https:\/\/doi.org\/10.1016\/s0968-0896(00)00166-8.","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"533_CR227","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","volume":"43","author":"N V\u00e1zquez-Laslop","year":"2018","unstructured":"V\u00e1zquez-Laslop N, Mankin AS. How macrolide antibiotics work. Trends Biochem Sci. 2018;43(9):668\u201384. https:\/\/doi.org\/10.1016\/j.tibs.2018.06.011.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"533_CR228","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1039\/c8ra09792e","volume":"9","author":"AM Prior","year":"2019","unstructured":"Prior AM, Sun D. Total synthesis of diazaquinomycins H and J using double Knorr cyclization in the presence of triisopropylsilane. RSC Adv. 2019;9(4):1759\u201371. https:\/\/doi.org\/10.1039\/c8ra09792e.","journal-title":"RSC Adv"},{"issue":"9\u201310","key":"533_CR229","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10295-019-02187-1","volume":"46","author":"J Braesel","year":"2019","unstructured":"Braesel J, Tran TA, Eust\u00e1quio AS. Heterologous expression of the diazaquinomycin biosynthetic gene cluster. J Ind Microbiol Biotechnol. 2019;46(9\u201310):1359\u201364. https:\/\/doi.org\/10.1007\/s10295-019-02187-1.","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"2\u20133","key":"533_CR230","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.envexpbot.2008.11.007","volume":"65","author":"P Babula","year":"2009","unstructured":"Babula P, Adam V, Kizek R, Sladk\u00fd Z, Havel L. Naphthoquinones as allelochemical triggers of programmed cell death. Environ Exp Bot. 2009;65(2\u20133):330\u20137. https:\/\/doi.org\/10.1016\/j.envexpbot.2008.11.007.","journal-title":"Environ Exp Bot"},{"issue":"12","key":"533_CR231","first-page":"1435","volume":"11","author":"C M\u00e9ndez","year":"2011","unstructured":"M\u00e9ndez C, Koskinen AMP, Salas JA. Antitubercular agents from actinomycetes: synthesis and medicinal chemistry. Curr Top Med Chem. 2011;11(12):1435\u201351.","journal-title":"Curr Top Med Chem"},{"key":"533_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2341","author":"MM Zhang","year":"2017","unstructured":"Zhang MM, Wong FT, Wang Y, Luo S, Lim YH, Heng E, et al. CRISPR-Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters. Nat Chem Biol. 2017. https:\/\/doi.org\/10.1038\/nchembio.2341.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"533_CR233","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/acsinfecdis.3c00592","volume":"10","author":"IV Krieger","year":"2024","unstructured":"Krieger IV, Yalamanchili S, Dickson P, Engelhart CA, Zimmerman MD, Wood J, et al. Inhibitors of the thioesterase activity of Mycobacterium tuberculosis Pks13 discovered using DNA-encoded chemical library screening. ACS Infect Dis. 2024;10(5):1561\u201375. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00592.","journal-title":"ACS Infect Dis"},{"issue":"6","key":"533_CR234","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1021\/acsinfecdis.4c01054","volume":"11","author":"BS Obadawo","year":"2025","unstructured":"Obadawo BS, Bartolomeu Halicki PC, Becker KL, Seeliger JC, Rohde KH, Sucheck SJ. Discovery of 2,4,5-substituted benzoxazole derivatives as Pks13 inhibitors via the scaffold hopping strategy. ACS Infect Dis. 2025;11(6):1460\u201372. https:\/\/doi.org\/10.1021\/acsinfecdis.4c01054.","journal-title":"ACS Infect Dis"},{"issue":"4","key":"533_CR235","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11274-017-2233-6","volume":"33","author":"S Chen","year":"2017","unstructured":"Chen S, Kinney WA, Van Lanen S. Nature\u2019s combinatorial biosynthesis and recently engineered production of nucleoside antibiotics in Streptomyces. World J Microbiol Biotechnol. 2017;33(4):66. https:\/\/doi.org\/10.1007\/s11274-017-2233-6.","journal-title":"World J Microbiol Biotechnol"},{"issue":"3","key":"533_CR236","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1074\/jbc.271.3.1579","volume":"271","author":"JA Tercero","year":"1996","unstructured":"Tercero JA, Espinosa JC, Lacalle RA, Jim\u00e9nez A. The biosynthetic pathway of the aminonucleoside antibiotic puromycin, as deduced from the molecular analysis of the pur cluster of Streptomyces alboniger. J Biol Chem. 1996;271(3):1579\u201390. https:\/\/doi.org\/10.1074\/jbc.271.3.1579.","journal-title":"J Biol Chem"},{"issue":"4","key":"533_CR237","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/AAC.43.4.727","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999;43(4):727\u201337. https:\/\/doi.org\/10.1128\/AAC.43.4.727.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"533_CR238","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027029","volume":"6","author":"KM Krause","year":"2016","unstructured":"Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: an overview. Cold Spring Harb Perspect Med. 2016;6(6): a027029. https:\/\/doi.org\/10.1101\/cshperspect.a027029.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"533_CR239","doi-asserted-by":"publisher","first-page":"e00917","DOI":"10.1128\/aac.00917-23","volume":"68","author":"K Hosoda","year":"2024","unstructured":"Hosoda K, Koyama N, Shigeno S, Nishimura T, Hasegawa N, Kanamoto A, et al. Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrob Agents Chemother. 2024;68(3):e00917-e923. https:\/\/doi.org\/10.1128\/aac.00917-23.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"533_CR240","doi-asserted-by":"publisher","first-page":"580","DOI":"10.7164\/antibiotics.56.580","volume":"56","author":"M Igarashi","year":"2003","unstructured":"Igarashi M, Nakagawa N, Doi N, Hattori S, Naganawa H, Hamada M, Caprazamycin B. a novel anti-tuberculosis antibiotic, from Streptomyces sp. J Antibiot. 2003;56(6):580\u20133. https:\/\/doi.org\/10.7164\/antibiotics.56.580.","journal-title":"J Antibiot"},{"issue":"19","key":"533_CR241","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1016\/j.bmcl.2012.08.003","volume":"22","author":"M Gan","year":"2012","unstructured":"Gan M, Zheng X, Liu Y, Guan Y, Xiao C. Three new 12-carbamoylated streptothricins from Streptomyces sp. I08A 1776. Bioorg Med Chem Lett. 2012;22(19):6151\u20134. https:\/\/doi.org\/10.1016\/j.bmcl.2012.08.003.","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"533_CR242","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.3390\/md12126102","volume":"12","author":"Y Bu","year":"2014","unstructured":"Bu Y, Yamazaki H, Ukai K, Namikoshi M. Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A. Mar Drugs. 2014;12(12):6102\u201312. https:\/\/doi.org\/10.3390\/md12126102.","journal-title":"Mar Drugs"},{"issue":"12","key":"533_CR243","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1021\/np300387n","volume":"75","author":"L Ding","year":"2012","unstructured":"Ding L, Maier A, Fiebig HH, Lin WH, Peschel G, Hertweck C. Kandenols A-E, eudesmenes from an endophytic Streptomyces sp. of the mangrove tree Kandelia candel. J Nat Prod. 2012;75(12):2223\u20137. https:\/\/doi.org\/10.1021\/np300387n.","journal-title":"J Nat Prod"},{"issue":"9","key":"533_CR244","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/md17090529","volume":"17","author":"DD Cao","year":"2019","unstructured":"Cao DD, Trinh TTV, Mai HDT, Vu VN, Le HM, Thi QV, et al. Antimicrobial lavandulylated flavonoids from a sponge-derived Streptomyces sp. G248 in East Vietnam Sea. Mar Drugs. 2019;17(9):529. https:\/\/doi.org\/10.3390\/md17090529.","journal-title":"Mar Drugs"},{"issue":"11","key":"533_CR245","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1007\/s12010-023-04403-2","volume":"195","author":"M Kaari","year":"2023","unstructured":"Kaari M, Joseph J, Manikkam R, Kalyanasundaram R, Sivaraj A, Anbalmani S, et al. A novel finding: 2,4-Di-tert-butylphenol from Streptomyces bacillaris ANS2 effective against Mycobacterium tuberculosis and cancer cell lines. Appl Biochem Biotechnol. 2023;195(11):6572\u201385. https:\/\/doi.org\/10.1007\/s12010-023-04403-2.","journal-title":"Appl Biochem Biotechnol"},{"issue":"28","key":"533_CR246","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1002\/anie.202003094","volume":"59","author":"CM Serrano","year":"2020","unstructured":"Serrano CM, Kanna Reddy HR, Eiler D, Koch M, Tresco BIC, Barrows LR, et al. Unifying the aminohexopyranose-and peptidyl-nucleoside antibiotics: implications for antibiotic design. Angew Chem Int Ed Engl. 2020;59(28):11330\u20133. https:\/\/doi.org\/10.1002\/anie.202003094.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"533_CR247","doi-asserted-by":"publisher","first-page":"15248","DOI":"10.1038\/s41598-023-41296-x","volume":"13","author":"S Devi","year":"2023","unstructured":"Devi S, Sharma M, Manhas RK. Purification and biological analysis of antimicrobial compound produced by an endophytic Streptomyces sp. Sci Rep. 2023;13(1):15248. https:\/\/doi.org\/10.1038\/s41598-023-41296-x.","journal-title":"Sci Rep"},{"issue":"5","key":"533_CR248","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijmm.2019.05.004","volume":"309","author":"F Wiker","year":"2019","unstructured":"Wiker F, Hauck N, Grond S, Gust B. Caprazamycins: Biosynthesis and structure activity relationship studies. Int J Med Microbiol. 2019;309(5):319\u201324. https:\/\/doi.org\/10.1016\/j.ijmm.2019.05.004.","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"533_CR249","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12934-022-01955-6","volume":"21","author":"D B\u00e4r","year":"2022","unstructured":"B\u00e4r D, Konetschny B, Kulik A, Xu H, Paccagnella D, Beller P, et al. Origin of the 3-methylglutaryl moiety in caprazamycin biosynthesis. Microb Cell Fact. 2022;21(1):232. https:\/\/doi.org\/10.1186\/s12934-022-01955-6.","journal-title":"Microb Cell Fact"},{"issue":"1","key":"533_CR250","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44259-023-00020-5","volume":"2","author":"E Franck","year":"2024","unstructured":"Franck E, Crofts TS. History of the streptothricin antibiotics and evidence for the neglect of the streptothricin resistome. NPJ Antimicrob Resist. 2024;2(1):3. https:\/\/doi.org\/10.1038\/s44259-023-00020-5.","journal-title":"NPJ Antimicrob Resist"},{"issue":"5","key":"533_CR251","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002091","volume":"21","author":"CE Morgan","year":"2023","unstructured":"Morgan CE, Kang YS, Green AB, Smith KP, Dowgiallo MG, Miller BC, et al. Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome. PLoS Biol. 2023;21(5): e3002091. https:\/\/doi.org\/10.1371\/journal.pbio.3002091.","journal-title":"PLoS Biol"},{"issue":"1","key":"533_CR252","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/md21010050","volume":"21","author":"JT Wibowo","year":"2023","unstructured":"Wibowo JT, Bayu A, Aryadi WD, Fernandes C, Yanuar A, Kijjoa A, et al. Secondary metabolites from marine-derived bacteria with antibiotic and antibiofilm activities against drug-resistant pathogens. Mar Drugs. 2023;21(1):50. https:\/\/doi.org\/10.3390\/md21010050.","journal-title":"Mar Drugs"},{"issue":"1","key":"533_CR253","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ja.2017.126","volume":"71","author":"M Igarashi","year":"2017","unstructured":"Igarashi M, Ishizaki Y, Takahashi Y. New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development. J Antibiot. 2017;71(1):15\u201325. https:\/\/doi.org\/10.1038\/ja.2017.126.","journal-title":"J Antibiot"},{"issue":"8","key":"533_CR254","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.tips.2016.05.001","volume":"37","author":"MG Moloney","year":"2016","unstructured":"Moloney MG. Natural products as a source for novel antibiotics. Trends Pharmacol Sci. 2016;37(8):689\u2013701. https:\/\/doi.org\/10.1016\/j.tips.2016.05.001.","journal-title":"Trends Pharmacol Sci"},{"key":"533_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2024.103162","volume":"88","author":"DJ Newman","year":"2024","unstructured":"Newman DJ. Something \u2018Old, New, Borrowed, or Blue\u2019, the search for Mother Nature\u2019s bioactive agents. Curr Opin Biotechnol. 2024;88: 103162. https:\/\/doi.org\/10.1016\/j.copbio.2024.103162.","journal-title":"Curr Opin Biotechnol"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-025-00533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-025-00533-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-025-00533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:12:40Z","timestamp":1757347960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-025-00533-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":255,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1007\/s13659-025-00533-8","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have read the final manuscript and approved the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"52"}}